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ABSTRACT 
 
Rheumatoid arthritis (RA) is an autoimmune disease affecting nearly 1% of the world’s 
population with symptoms such as inflammation, pain, and reduced strength [1].  Physicians and 
scientists work to develop pharmaceuticals and medical devices aimed at decreasing the 
symptoms associated with RA to better the lives of those affected. One of the most recent 
developments is the addition of thermal therapy gloves to the array of upper limb orthoses 
available to patients with RA. It was hypothesized that this study will show that orthoses in the 
form of thermal therapy gloves are beneficial to the patients by reducing symptoms such as pain 
and allowing them an increased range of motion and overall hand functionality. Patients in stage 
2 were recruited and asked to first complete a personal history survey including the Health 
Assessment Questionnaire (HAQ) [2] and Pain Catastrophizing Scale (PCS) [3]. Range of 
motion tasks and the Arthritis Hand Function Test (AHFT) [4] were completed to determine the 
effect of two thermal therapy gloves on the range of motion and activities of daily living. The 
data suggests that the use of thermal therapy orthoses does provide a psychological advantage in 
the form of reduced perceived pain along with the advantage of being able to complete activities 
previously believed to be impossible for participants to complete. Additionally, it is suggested 
that heat-generating material be used in the manufacturing of these orthoses in order to remove 
the need for any further design modifications. Future studies should be conducted in order to 
analyze the long-term effects of these orthoses along with the possible psychological benefits of 
their use.   
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CHAPTER 1: INTRODUCTION 
 
1.1 Rheumatoid Arthritis 
 
Rheumatoid arthritis (RA) is an autoimmune disease that affects close to 1% of the 
world’s population. RA symptoms include inflammation, pain, and reduced strength therefore 
reducing the quality of life of the patient [1]. There is very little clinical evidence supporting the 
use of non-pharmaceutical treatments for patients suffering from RA. This pilot study aims to 
provide useful information on orthotic treatments for patients suffering from RA in their hands 
and wrists. 
1.2 Gap in Knowledge 
 
Rheumatoid Arthritis (RA) is a very common disease, affecting close to 2 million people 
in the United States alone [5]. Physicians and scientists work to develop pharmaceuticals and 
medical devices aimed at decreasing the symptoms associated with RA to better the lives of 
those affected. One of the most recent developments is the addition of thermal therapy gloves to 
the array of upper limb orthoses available to patients with RA. These gloves have been widely 
accepted by patients but have very little scientific evidence supporting the claims of 
manufacturers. In a literature review recently published by the author, the effectiveness of upper-
limb orthoses used in RA was evaluated to assess the overall use of orthoses compared to 
traditional interventions [6]. The intent of this pilot study is to determine the effectiveness of two 
different thermal therapy gloves on the symptoms of rheumatoid arthritis.  
  2 
1.3 Importance of Range of Motion 
 
Maintaining a somewhat normal range of motion (ROM) is critical in order to prevent the 
decrease in hand function and the overall quality of life for the patient. ROM is directly linked to 
hand function performance and being able to carry out activities of daily living independently 
[7]. Due to the importance of these factors, an array of ROM tests are performed in this pilot 
study in order to accurately address the correlation between a patient’s ROM and their capacity 
to complete certain activities of daily living.  
1.4 Importance of Performing Daily Activities 
 
Activities of daily living (ADL) such as buttoning a shirt, tying a shoelace, or pouring a 
glass of water can be very strenuous for patients with diseases such as rheumatoid arthritis. The 
ability to perform ADLs is linked to the overall independence of the patient and their quality of 
life [7]. ADLs were tested in this study by performing the Arthritis Hand Function Test and 
measuring the capabilities of each patient. 
1.5 Hypothesis 
 
It is hypothesized that this study will show that orthoses in the form of thermal therapy 
gloves are beneficial to the patients by reducing symptoms such as pain and allowing them an 
increased range of motion and overall hand functionality. 
 
 
 
 
 
 
  3 
1.6 Specific Aims and Objectives 
 
Aim 1: Determine if each thermal therapy arthritic glove increases range of motion [8, 9] in 
patients by comparing the performance with and without the gloves 
 
Aim 2: Determine if each thermal therapy arthritic glove decreases the amount of pain 
experienced by the patient when completing specific tasks using the Rheumatoid Arthritis Pain 
Scale [10]. 
 
Aim 3: Determine if each thermal therapy arthritic glove increases hand strength, dexterity and 
overall function using the Arthritis Hand Function Test [4]. 
 
Aim 4: Determine the advantages and disadvantages of each thermal therapy arthritic glove by 
comparing the results of each test. 
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CHAPTER 2: BACKGROUND 
 
2.1 Rheumatoid Arthritis 
2.1.1 Overview 
 
Rheumatoid arthritis, one of the most common forms of arthritis, is a chronic 
inflammatory disease affecting joints. The most common joints affected are the proximal 
interphalangeal joints, metacarpophalangeal joints, wrists, knees, ankles, and toes [5]. The 
worldwide prevalence of RA is 0.5-1% in developed countries [5]. Within the United States, the 
current prevalence of RA is as high as 0.6% [5] affecting nearly 1.5 million people [11]. 
Typically, the onset of the disease occurs between 30-60 years of age [14] and women are 
diagnosed three times as often as men [12]. The severity of RA and how it affects the patient 
varies; allowing some individuals to carry out their normal life while others are disabled within 
years of the initial diagnosis. Of those patients who were working at the time of the diagnosis, 
20-70% were disabled and no longer able to work after 7-10 years [13].  
2.1.2 Causes  
 
Although the single root cause of RA is unknown, studies have shown that factors such as 
environment, hormones, and genetics play a large role [14]. In addition to genetic causes, studies 
show that physical trauma can also lead to the onset of RA [15]. These factors trigger a reaction 
of the immune system which leads to the development of the disease [16].  
  5 
2.1.3 Symptoms  
 
Patients with RA experience a variety of symptoms that can range from being 
manageable to debilitating. Forty percent of early RA patients have swelling in their finger 
joints, mainly the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints. This 
then leads to the hand and wrist being affected within four months of the initial swelling [17]. In 
long standing RA patients, the hand is affected in 85% of all patients and ulnar deviations at the 
MCP joints are found in 45% of all patients [17]. Other symptoms include pain, stiffness, 
tenderness, deformed joints, Carpal Tunnel syndrome, and fatigue [17]. Patients experience a 
decrease in their ability to complete activities of daily living (ADL) because of these symptoms 
and with that, a decline in their overall quality of life.  
2.1.4 Diagnosis 
 
Rheumatoid arthritis is defined using classification criteria in order to properly diagnose 
and treat those with and without RA. Historically, patients showing symptoms of RA have been 
difficult to definitively diagnose as having RA due to the varying range of classifications used by 
physicians. The most commonly used set of criterion was previously created in 1987 by the 
American College of Rheumatology [18]. These criteria were well accepted but contained 
limitations that hindered diagnosis and consequently, treatment. Therefore, in 2008 the American 
College of Rheumatology and the European League Against Rheumatism began developing new 
classification criteria for RA. The new system uses weighted classifications on a scoring system 
to quantify the symptoms of each patient and relate the score to the severity and diagnosis of 
rheumatoid arthritis. These new criteria allow for much more specific classifications and much 
earlier diagnoses [18].  
  6 
For the purpose of this study, stages were classified based on the extent of cartilage and 
bone damage as seen via traditional x-rays [19]. Since the new classification criteria developed 
by the American College of Rheumatology and the European League Against Rheumatism 
moves away from specific levels of the disease and more towards a case by case treatment, it was 
decided to classify subjects based on traditional stages using x-rays for the purpose of grouping 
and analysis. The classification studied were participants with stage 2; cartilage damage [19]. 
Stage 1 participants were not included in this study because patients in stage 1 have early stage 
cartilage damage and typically do not require as much treatment as those in stage 2 or stage 3 
[19]. Similarly, patients classified as stage 4 were not included because the extent of the bone 
erosion and cartilage damage is too great to benefit from orthoses [19]. Patients categorized as 
stage 3 should be included in future studies. 
2.1.5 Treatments  
 
Patients with rheumatoid arthritis (RA) suffer from symptoms such as pain, loss of 
function, and joint damage. Treatments aim to prevent these and other symptoms from occurring 
through the use of pharmaceuticals, exercises, assistive devices, or other types of therapies [20]. 
The rheumatoid arthritis pharmaceutical industry is a multibillion-dollar industry with 10 large 
companies dominating the market [21]. These medications are disease-modifying antirheumatic 
drugs (DMARDs), corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs) [22]. In 
addition to pharmacologic interventions, treatments such as exercise, joint protection, assistive 
technology, thermotherapy, dieting, and occupational or physical therapy are widely used by 
patients suffering from RA [11, 20, 23]. Additionally, copper is sometimes used to treat RA both 
intravenously [24] and when manufactured into clothes, jewelry or orthoses [25]. As a last resort, 
surgical interventions such as arthroplasty and joint replacement can be performed to help treat 
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the symptoms of RA [26]. However, only 315,000, 21%, of patients typically receive surgical 
interventions as compared to the 1.5 million Americans living with the disease [26]. 
2.2 Orthoses 
2.2.1 Static 
 
Static resting splints are the most common orthosis used to treat rheumatoid arthritis 
(RA). These orthoses hold the metacarpal joints in a slight flexion in order to place the hand in 
the ideal anatomical position to reduce swelling, improve hand function, and prevent deformity 
[17]. Static resting splints have been around since the early 1900’s and have been used for post-
operative care [27]. Although shown to decrease symptoms such as morning stiffness [17], static 
orthoses significantly decrease range of motion (ROM) to the point of patients no longer being 
able to use the affected hand when completing ADLs. Additionally, a recent study found no 
significant change in grip strength of individuals using static orthoses over the course of a year 
[17]. 
2.2.1.1 Current Research in Static Orthoses 
 
Static orthoses are used to immobilize the affected appendage or joint, such as the hand 
and wrist, in order to reduce the swelling and pain. By immobilizing the joints, there is a 
decrease of friction and temperature which also decreases the symptoms commonly felt by 
patients [17]. However, these static orthoses severely reduce the independence of the user 
depending upon the extent of immobility. Previous studies show that over an extended period of 
time, static orthoses aid in decreasing the symptoms of RA. Yet these studies also disclose that 
the decrease is not statistically significant in addition to the uncertainty of whether or not patients 
were actually wearing the orthoses for the desired amount each day [1, 28]. 
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2.2.2 Dynamic 
 
Dynamic hand-wrist orthoses allow for patients to maintain a proper anatomic position 
while having the opportunity to maintain limited range of motion. Similar to static orthoses, 
dynamic orthoses have been around since the 1900’s and were originally used for post-operative 
patient care [27]. Orthoses of this type are used to assist individuals who are unable to make a 
functional grasp, however, they are generally used for stroke patients where paralysis, not pain, 
is the limiting factor [29]. When using a dynamic orthosis, a patient must use their own muscles 
to begin the motion while the orthosis aids in motion stability [30]. This is often painful for 
patients suffering from RA as they may not have the force required to begin the movement of the 
orthosis [30]. However, these orthoses allow for the hand and wrist to remain in the anatomically 
correct position [30]. For this reason, typical dynamic orthoses provide no more advantage than 
static orthoses, which is why this study looked at a different form of dynamic orthoses.  
2.2.2.1 Current Research in Dynamic Orthoses 
 
Dynamic hand-wrist orthoses are used to assist individuals who are unable to make a 
functional grasp. Although RA patients do use dynamic orthosis to potentially aid in the relief of 
symptoms, they are typically used on stroke patients where paralysis, not pain, is the limiting 
factor [29]. For this reason, there is a lack of studies looking at the effects of a traditional 
dynamic hand wrist orthosis on RA patients. 
2.2.3 Powered 
 
Powered orthoses and prostheses have been around since the 1940’s, correlating with the 
invention of the powered tools. From their inception as an aid to factory workers with amputated 
limbs, powered orthoses have been focused on rehabilitation and quality of life improvement 
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[31]. Powered orthoses are used by patients who do not have the ability to perform simple hand 
functions on their own [31]. For patients with severe RA, these orthoses allow them to regain a 
level of independence that may have been previously lost due to their condition. According to 
Pawel Maciejasz, who conducted a recent survey on robotic devices for upper limb 
rehabilitation, there is a significant need for powered hand wrist orthoses to aid users in 
rehabilitation and completing daily activities, but few of such devices have been proposed. 
Maciejasz found that there are no orthoses that would allow for the wide range of wrist and 
finger motion similar to those that dynamic orthoses provide the user. Some of the biggest 
drawbacks to any powered hand orthosis are cost, weight, portability, and charge/battery life. A 
powered hand orthosis is designed to help in activity completion meaning it will need to support 
movement of multiple joints. This support is gained by the installment and use of actuators 
and/or other necessary parts, which increases the overall cost and weight of the orthosis and 
makes it less portable. Additionally, the amount of available energy is limited to storage capacity 
[32]. 
2.2.3.1 Current Research in Powered Orthoses 
 
The W-EXOS is a powered orthosis that assists with forearm and wrist motion through 
electromyography (EMG) based fuzzy-neuro control. This fuzzy-neuro control method 
implements fuzzy if-then rules to determine the required torque to the motor, according to the 
intended motion, to ultimately obtain natural and flexible motion assist. The main drawback of 
this type of a powered orthosis is the control method working universally; difficulty in defining 
the fuzzy if-then logic that is applied to devices with higher degrees of freedom cause some 
motions to be unnatural and inflexible [33].  
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The active support splint driven by soft pneumatic actuator (ASSIST) helps assist 
individuals with wrist bending motion. When the ASSIST is in its initial state the wrist is in a 
relaxed position, and when the ASSIST is in a pressurized state wrist flexion is achieved. The 
ASSIST has been effective in decreasing muscle fatigue but was unclear in whether it increased 
muscle strength and/or whether it is effective in decreasing pain when assisting the user in 
completing tasks [34]. 
After gathering information on the use and different types of powered orthoses, it was 
determined that these orthoses were not as frequently used by patients with RA because of the 
apparent reduction of independence and the bulk of the assistive technology. Therefore, an 
alternative type of dynamic orthoses, thermal therapy gloves, were chosen to be included in this 
study.  
2.2.4 Thermal Therapy Gloves 
 
Thermal therapy gloves are widely recommended by occupational therapists to patients 
with rheumatoid arthritis for the purpose of decreasing pain and allowing the patient to have 
more use of the affected hand and wrist. Although different forms of these gloves have been in 
use since the 1970’s, there is little evidence supporting their effectiveness [35].  
These orthoses are much less bulky than the traditional static orthoses or the possibly 
painful dynamic orthoses typically used by RA patients to alleviate stress on their joints. 
Additionally, these gloves allow the patient to maintain a level of independence by granting them 
a class of range of motion that traditional orthoses hinder [35]. 
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2.2.4.1 Current Research in Thermal Therapy Gloves 
 
There is a scarce amount of research previously conducted with regards to thermal 
therapy gloves. Siti Hana Nasir, Olga Troynikov and Nicola Massy-Westropp conducted a 
literature review in 2014 where eight studies were reviewed and seven outcome measures 
evaluated in order to determine the “effects of wearing therapy gloves on patients’ hand function 
and symptoms” [35]. This literature review looked at hand pain, stiffness, swelling, grip strength 
and overall function as some of the outcome measures however, it was found that there was 
marginal or no improvement in hand function when using thermal therapy gloves. Pain, stiffness, 
swelling and grip strength did improve with the use of these gloves. This literature review 
suggests further research aiming at quantifying the effectiveness of therapy gloves in regards to 
hand function and glove performance. 
Recently, the Centre for Health Sciences Research at the University of Salford conducted 
a study comparing the effectiveness of compression gloves at night for patients with rheumatoid 
arthritis and hand osteoarthritis. This study reported a significant reduction in finger joint 
swelling in rheumatoid arthritis patients however, the study was deemed inconclusive due to 
unsatisfactory data reporting. This study, conducted in early 2016, highlights the need for 
additional investigation into the effectiveness of therapy gloves [36].   
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CHAPTER 3: METHODOLOGY 
 
This randomized control trial included patients classified as having stage 2 Rheumatoid 
Arthritis, who were asked to perform specific ranges of motion and activities of daily living four 
separate times; once without the aid of an orthosis (control), once with a placebo orthosis, once 
with the first thermal therapy glove, and once with the second thermal therapy glove.  
3.1 Inclusion/Exclusion Criteria 
 
Patients must have been able to understand the informed consent form and suffer from 
diagnosed rheumatoid arthritis in their hands. Patients must have been at least eighteen years old 
and able to follow directed activities. A total of five patients were included in this study, all 
categorized as stage 2.  
The different stages of RA were classified based on the traditional categorizations 
determined by X-ray and ultrasound screenings. A patient was considered to be in stage 1 if they 
had inflammation in the joint capsule and swelling of the synovial tissue surrounding the area but 
they did not have any permanent damage or deterioration. Stage 2 was if the inflammation of the 
synovial tissue causes cartilage damage but there was no bone deterioration. A patient was 
considered to be in stage 3 if the inflammation had caused both cartilage damage and bone 
deterioration. The final stage, stage 4, was when the inflammatory process ends and the joints 
were fused together, causing them to stop working completely [37].  
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3.2 Patient History Survey (See Appendix A) 
3.2.1 General History Questions 
 
General information was collected from each subject such as age, gender, and year of 
diagnosis. This information was collected for the purpose of analyzing results based on factors 
such as gender and if the patient had ever used an orthosis for their RA.  
3.2.2 Health Assessment Questionnaire 
 
The Health Assessment Questionnaire (HAQ), developed by Stanford University, was 
developed to gather information on the quality of life of patients living with a disease or 
impairment [2]. The HAQ used in this study was based off of the original Stanford HAQ and was 
used to evaluate the limitations of the patient during their daily life. Sample questions were: 
• When you wake up in the morning, do you ache? ____ Y ____ N 
o If yes, how long does your pain last?  _____ hours _____ minutes 
• I exercise ___ daily ___ weekly ___ monthly 
• I ___ walk ___ do yoga ___ water exercises ___ garden ___ dance ______ other 
3.2.3 Pain Catastrophizing Scale 
 
Included in the patient history survey was the Pain Catastrophizing Scale (PCS) (Table 
1), developed and validated by Michael JL Sullivan in 1995. The Pain Catastrophizing Scale 
(PCS) was developed in order to measure the psychological effect of pain and the “mechanisms 
by which catastrophizing impacts on pain experience” [3]. This scale gives information on the 
patient’s mentality towards their pain and can be used to shed light on clustered results (i.e. if 
results are in two clusters, one may have a high PCS score and the other may have a low PCS 
score).  
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Table 1: Pain Catastrophizing Scale Questions [3] 
1. I worry all the time about whether the pain will end 
2. I feel I can’t go on 
3. It’s terrible and I think it’s never going to get any better 
4. It’s awful and I feel that it overwhelms me 
5. I feel I can’t stand it anymore 
6. I become afraid that the pain will get worse 
7. I keep thinking of other painful events 
8. I anxiously want the pain to go away 
9. I can’t seem to keep it out of my mind 
10. I keep thinking about how much it hurts 
11. I keep thinking about how badly I want the pain to stop 
12. There’s nothing I can do to reduce the intensity of the pain 
13. I wonder whether something serious may happen 
 
3.3 Arthritis Hand Function Test (See Appendix B) 
3.3.1 Purpose 
 
The Arthritis Hand Function Test (AHFT) was created to aid therapists in evaluating the 
strength and dexterity of patients with osteoarthritis and rheumatoid arthritis [4]. The test covers 
strength, applied strength, dexterity, and applied dexterity by completing the following tasks: 
 
Table 2: Arthritis Hand Function Test [4] 
Strength Grip and Pinch Strength 
Applied Strength Pouring Water 
Dexterity Pegboard 
Applied Dexterity Shoe Lacing, Button Board, Safety Pins, Eating Utensils, Coin Pick-Up 
 
These specific tasks provided insight into general activities of daily living and how well 
the patient is able to perform them.  
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3.3.2 Overview 
 
Each patient participated in The Arthritis Hand Function Test which measured their hand 
strength, dexterity, and overall hand function. Each participant repeated the test four times: first, 
without any orthosis; second, with the placebo glove; third, with the IMAK Compression 
Arthritis Gloves; and fourth, with the Veturo Infrared Therapy Gloves. The order of these trials 
was randomized for each subject. The measurements taken during this test included but were not 
limited to grip and pinch strength, pegboard dexterity, manipulating coins, and pouring a glass of 
water [4]. The scores of the test were compared to a Hand Function Profile sheet appropriate for 
the age and sex of the patient, which provided the normal measurements for each test [4].  
The Arthritis Hand Function Test was chosen because it was specifically tested and 
designed for patients with rheumatoid arthritis and has been proven to be a valid and reliable 
testing method [4, 38]. The AHFT was chosen over similar tests, such as the Jebsen Hand 
Function Test or the Michigan Hand Outcomes Questionnaire [39], because it is specific to 
arthritis and has been validated using patients with rheumatoid arthritis. Other hand function 
tests, although similar, are not specific to RA.  
3.4 Range of Motion Tasks (See Appendix C) 
3.4.1 Purpose 
 
One of the more severe symptoms of RA is the reduction of the range of motion of the 
affected joints, limiting the activities of daily living a person can complete [17]. Although 
activities of daily living were tested using the Arthritis Hand Function Test (AHFT), including 
specific range of motion exercises allowed for a broader view of the abilities of each patient 
outside of the specific tasks being performed in the AHFT. 
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3.4.2 Overview 
 
When assessing range of motion each patient performed specific, measured movements 
first without the aid of any orthoses and then with each of the gloves, giving a total of four sets 
of range of motion data (i.e. “Range of Motion without Orthosis”, “Range of Motion with 
IMAK”, etc.).  Additionally, each data set was broken down into two subsets; fingers and 
thumbs. During each data set patients were asked to perform simple range of motion movements 
to the best of their ability. The measurements of the fingers subset were [9]: 
• Metacarpophalangeal Flexion and Extension 
• Proximal Interphalangeal Flexion and Extension 
The measurements of the thumb subset were [9]: 
• Carpometacarpal Abduction and Adduction 
• Metacarpophalangeal Flexion and Extension 
Motion capture was used to measure these range of motion tests as it is more precise than using a 
goniometer and has a smaller error rate. 
The ranges of motion being tested were chosen because they are specific to the joints 
affected by rheumatoid arthritis. The metacarpophalangeal joints, and proximal interphalangeal 
joints are affected whereas the distal interphalangeal joint is not affected by RA and was 
therefore not included in the range of motion tasks being studied [40].  
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3.5 Rheumatoid Arthritis Pain Scale  
3.5.1 Purpose 
 
The Rheumatoid Arthritis Pain Scale (RAPS) is an adaptation from the Likert Scale and 
was developed to create a clinical instrument for measuring the symptom of pain in adults with 
RA [41]. The RAPS is widely used and has been clinically validated to warrant more use [42]. 
3.5.2 Overview 
 
In order to establish a baseline for each patient, all data collection periods began with the 
patient rating their current level of pain based on the Rheumatoid Arthritis Pain Scale (RAPS). 
Patients were asked to continuously rate the level of pain being experienced throughout the data 
collection period and during each individual task or movement.  
 
Figure 1: Rheumatoid Arthritis Pain Scale (RAPS) [41] 
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The Rheumatoid Arthritis Pain Scale (RAPS) is a Visual Analogue Scale and was chosen 
because it was developed and tested specifically for patients suffering from RA by Stanford 
University and is based off the common Likert Scale [10].  
As opposed to other common pain scales used in the medical field, the RAPS has been 
adapted specifically for patients with rheumatoid arthritis. Other common validated scales, such 
as the Wong-Baker Facial Pain Scale and the McGill Pain Questionnaire (MPQ), are either 
specified to other groups, such as pediatric for the Wong-Baker Facial Scale, or are too general, 
as with the MPQ [43, 44, 45]. These pain scales may result in similar results for this study, 
however, it was determined that the RAPS would be most applicable due to the specialization of 
rheumatoid arthritis.  
3.6 Additional Outcome Measures 
 
Additional outcome measures collected were the oxygen saturation of the blood and 
surface temperature of the subjects’ hands. These were collected using a pulse oximeter [46] and 
laser thermometer [47] respectively. The oxygen saturation and surface temperature were taken 
after each task (i.e. after each range of motion task, after each task within the Arthritis Hand 
Function Test). The blood oxygen saturation and surface temperature were collected because an 
increase in both was crucial to the arthritis gloves aiding symptoms such as pain and swelling 
[35]. 
3.7 Kinematic Motion Capture and Analysis 
 
The range of motion exercises were measured using the combination of a motion capture 
system, Vicon Nexus, and biomechanics analysis software, C-Motion Visual 3D.  
  19 
3.7.1 Vicon Motion Capture System 
 
The Vicon Motion Capture system used to collect kinematic range of motion data utilizes 
an 8-camera 3D set-up, this allows for a 3D global coordinate system to be estimated from 
multiple 2D views. Direct linear transformation is used which assumes a linear relationship 
between the 2D camera coordinates and the 3D coordinates of a marker. There are three different 
Cartesian coordinate systems required to successfully capture motion; the Global Coordinate 
System (GCS), Local Coordinate System (LCS), and the Force Platform Coordinate System 
(FCS). An important assumption regarding all of these systems is that of rigidity, although 
anatomically incorrect, it is crucial when defining body segments [48]. 
The GCS is the capture volume where the 3D space of the motion capture system is 
represented. All recorded data are logged into this system when using the Vicon Motion Capture 
System. This coordinate system is a right-handed orthogonal system with the vertical direction 
being the most important to define because of subject movement. The assumption of rigidity 
allows for segments to be effectively defined by an LCS which moves with the segment. Like the 
GCS, the LCS is a right-handed orthogonal system. The orientation of the LCS with respect to 
the GCS defines the orientation of a segment. In other words, as an object moves in the GSC, the 
endpoints move in the LCS and the transformation between the two systems allow for the linear 
and rotational description of movement [48]. 
In order to define a segment within the LCS 3 non-collinear points are required. The 
placement of these points, or markers, is used to establish the LCS and typically the XYZ axes 
are assigned posteriorly, anteriorly, and superiorly respectively. When creating segments, joint 
constraints are added in order to minimize the effect of soft tissue and measurement error. The 
system then searches for the optimal pose in each frame that allows for the minimum difference 
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between the measured and model-determined marker coordinates. This process allows for 
variability in the number of markers and marker segments based on the desired model output and 
the kinematics being studied [48].  
A benefit to using this specific system is that if there are missing markers in a frame, a lot 
of noise, or false markers, the segment and model can still be observable because of the joint 
constraints previously placed. The inclusion of these joint constraints minimizes soft tissue 
artifact and reduces the amount of noise and overall error during a study. A disadvantage of this 
system is analogous in that with the amount of extrapolation required of the system to replace a 
missing point in numerous frames, this then adds to the general error of each trial or movement 
[48]. 
3.7.2 Visual 3D Motion Analysis System 
 
After collecting the kinematic motion capture data using the Vicon Nexus System and 
removing any false markers, the model was transferred to the C-Motion Visual 3D system for 
processing and analysis. This system continues the use of the GCS and LCS right-handed 
orthogonal systems with the most important direction being that of the bone segment assigned as 
the Y-axis. This allows for the X-axis and Z-axis to be assigned based on the specific joint 
associated with the segment. For example, the pelvis would have the Y-axis assigned direction 
superiorly, X-axis assigned anteriorly, and the Z-axis would follow the right-hand rule pointing 
laterally away from the body [48]. 
This system was then used to discern the various movements of each point throughout the 
duration of a trial. The locations of these points were then compiled and analyzed to produce 
joint angles. An advantage of this system, similar to that of the Vicon system, is that the 
inclusion of the joint constraints minimizes soft tissue artifact and overall error during 
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processing. Lastly, a disadvantage carries over from the Vicon system in that when a marker, or 
point, is missing it creates a gap in data for that specific frame. Although it can be extrapolated, 
this adds to the potential for error [48]. 
3.7.3 Markers and Marker Segments 
 
Table 3: Marker Placement and Names (Torso, Pelvis, Arms, and Wrists) 
Torso 
Clavicle CLAV 
Sternum STRN 
Vertebrae Thoracicae 1 T1 
Vertebrae Thoracicae 10 T10 
Left Back LBAK 
Pelvis 
Left Anterior Superior Iliac Spine LASI 
Right Anterior Superior Iliac Spine RASI 
Left Posterior Superior Iliac Spine LPSI 
Right Posterior Superior Iliac Spine RPSI 
Arms 
Right Shoulder Anterior RHOA 
Right Shoulder Posterior RSHOP 
Left Shoulder Anterior LSHOA 
Left Shoulder Posterior LSHOP 
Right Elbow RELB 
Right Elbow Medial RELBM 
Left Elbow LELB 
Left Elbow Medial LELBM 
Wrists 
Right Wrist Anterior RWRA 
Right Wrist Medial RWRM 
Right Wrist Ulnar RWRU 
Left Wrist Anterior LWRA 
Left Wrist Medial LWRM 
Left Wrist Ulnar LWRU 
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Table 4: Marker Placement Names (Hands and Fingers) 
Hands 
and 
Fingers 
Right Metacarpal Finger 1 (Thumb) RM1 
Right Metacarpophalangeal Joint Finger 1 (Thumb) RMPP1 
Right Metacarpal Finger 2 (Pointer) RM2 
Right Metacarpophalangeal Joint Finger 2 (Pointer) RMPP2 
Right Metacarpal Finger 3 (Middle) RM3 
Right Metacarpophalangeal Joint Finger 3 (Middle) RMPP3 
Right Metacarpal Finger 4 (Ring) RM4 
Right Metacarpophalangeal Joint Finger 4 (Ring) RMPP4 
Right Metacarpal Finger 5 (Pinky) RM5 
Right Metacarpophalangeal Joint Finger 5 (Pinky) RMPP5 
Left Metacarpal Finger 1 (Thumb) LM1 
Left Metacarpophalangeal Joint Finger 1 (Thumb) LMPP1 
Left Metacarpal Finger 2 (Pointer) LM2 
Left Metacarpophalangeal Joint Finger 2 (Pointer) LMPP2 
Left Metacarpal Finger 3 (Middle) LM3 
Left Metacarpophalangeal Joint Finger 3 (Middle) LMPP3 
Left Metacarpal Finger 4 (Ring) LM4 
Left Metacarpophalangeal Joint Finger 4 (Ring) LMPP4 
Left Metacarpal Finger 5 (Pinky) LM5 
Left Metacarpal Finger 5 (Pinky) LMPP5 
Right Proximal Phalangeal Finger 1 (Thumb) RPP1 
Right Proximal Interphalangeal Joint Finger 1 (Thumb) RPDM1 
Right Proximal Phalangeal Finger 2 (Pointer) RPP2 
Right Proximal Interphalangeal Joint Finger 2 (Pointer) RPDM2 
Right Proximal Phalangeal Finger 3 (Middle) RPP3 
Right Proximal Interphalangeal Joint Finger 3 (Middle) RPDM3 
Right Proximal Phalangeal Finger 4 (Ring) RPP4 
Right Proximal Interphalangeal Joint Finger 4 (Ring) RPDM4 
Right Proximal Phalangeal Finger 5 (Pinky) RPP5 
Right Proximal Interphalangeal Joint Finger 5 (Pinky) RPDM5 
Left Proximal Phalangeal Finger 1 (Thumb) LPP1 
Left Proximal Interphalangeal Joint Finger 1 (Thumb) LPDM1 
Left Proximal Phalangeal Finger 2 (Pointer) LPP2 
Left Proximal Interphalangeal Joint Finger 2 (Pointer) LPDM2 
Left Proximal Phalangeal Finger 3 (Middle) LPP3 
Left Proximal Interphalangeal Joint Finger 3 (Middle) LPDM3 
Left Proximal Phalangeal Finger 4 (Ring) LPP4 
Left Proximal Interphalangeal Joint Finger 4 (Ring) LPDM4 
Left Proximal Phalangeal Finger 5 (Pinky) LPP5 
Left Proximal Interphalangeal Joint Finger 5 (Pinky) LPDM5 
Right Middle Phalangeal Finger 1 (Thumb) RMD1 
Right Proximal Interphalangeal Joint Finger 1 (Thumb) RPDM1 
Right Proximal Phalangeal Finger 2 (Pointer) RPP2 
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Table 4: Continued 
 
Hands 
and 
Fingers 
Cont. 
Right Proximal Interphalangeal Joint Finger 2 (Pointer) RPDM2 
Right Proximal Phalangeal Finger 3 (Middle) RPP3 
Right Proximal Interphalangeal Joint Finger 3 (Middle) RPDM3 
Right Proximal Phalangeal Finger 4 (Ring) RPP4 
Right Proximal Interphalangeal Joint Finger 4 (Ring) RPDM4 
Right Proximal Phalangeal Finger 5 (Pinky) RPP5 
Right Proximal Interphalangeal Joint Finger 5 (Pinky) RPDM5 
Right Distal Phalangeal Finger 1 (Thumb) RD1 
Right Distal Interphalangeal Joint Finger 2 (Pointer) RMD2 
Right Distal Phalangeal Finger 2 (Pointer) RD2 
Right Distal Interphalangeal Joint Finger 3 (Middle) RMD3 
Right Distal Phalangeal Finger 3 (Middle) RD3 
Right Distal Interphalangeal Joint Finger 4 (Ring) RMD4 
Right Distal Phalangeal Finger 4 (Ring) RD4 
Right Distal Interphalangeal Joint Finger 5 (Pinky) RMD5 
Right Distal Phalangeal Finger 5 (Pinky) RD5 
Left Middle Phalangeal Finger 1 (Thumb) LMD1 
Left Distal Phalangeal Finger 1 (Thumb) LD1 
Left Distal Interphalangeal Joint Finger 2 (Pointer) LMD2 
Left Distal Phalangeal Finger 2 (Pointer) LD2 
Left Distal Interphalangeal Joint Finger 3 (Middle) LMD3 
Left Distal Phalangeal Finger 3 (Middle) LD3 
Left Distal Interphalangeal Joint Finger 4 (Ring) LMD4 
Left Distal Phalangeal Finger 4 (Ring) LD4 
Left Distal Interphalangeal Joint Finger 5 (Pinky) LMD5 
Left Distal Phalangeal Finger 5 (Pinky) LD5 
 
 
Table 5: Marker Segments 
Pelvis Pelvis 
Torso Torso 
Right Upper Arm RUpper Arm 
Left Upper Arm LUpper Arm 
Right Lower Arm RLower Arm 
Left Lower Arm LLower Arm 
Right Metacarpal RMeta 
Left Metacarpal LMeta 
Right Proximal Phalangeal RPPhal 
Left Proximal Phalangeal LPPhal 
Right Middle-Distal Phalangeal RMDPhal 
Left Middle-Distal Phalangeal LMDPhal 
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Figure 2: Torso, Pelvis, Arms, and Wrist Markers 
 
 
Figure 3: Torso, Pelvis, Arms, and Wrists Markers (Vicon) 
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Figure 4: Torso, Pelvis, Arms, and Wrists Segments 
 
 
 
Figure 5: Torso, Pelvis, Arms, and Wrists Segments (Vicon) 
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Figure 6: Hand and Finger Markers 
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Figure 7: Hand and Finger Segments 
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Figure 8: Hand and Finger Markers and Segments (Vicon) Image 1 
 
 
 
Figure 9: Hand and Finger Markers and Segments (Vicon) Image 2 
 
3.8 Orthoses Being Tested 
 
The thermal therapy orthoses that were tested are the IMAK Compression Arthritis 
Gloves (Figure 10) [49] and Veturo Therapy Infrared Gloves (Figure 11) [50]. These gloves all 
claim to decrease pain, increase range of motion, increase hand strength, increase hand dexterity, 
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and increase hand function [51]. They are all currently the most popular thermal therapy gloves 
used by patients with rheumatoid arthritis however, there is little to no evidence supporting 
manufacturer claims [51].  
These gloves decrease pain and swelling by increasing the temperature of the hands and 
increasing blood oxygen levels [35]. They do not contain copper or any other known intervention 
used to treat diseases such as RA.  
 
 
Figure 10: IMAK Arthritis Gloves [49] 
 
 
 
Figure 11: Veturo Therapy Infrared Gloves [50] 
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3.9 Procedure 
 
Each patient performed four trials correlating to each intervention; control, placebo 
gloves, IMAK gloves, and Veturo gloves. The order of the trials was randomized using a 
standard random number generator however, each trial procedure remained constant. After 
appropriate consent forms were completed, the following procedure was followed for each trial.  
• Fit Glove Sizes 
• Warm-Up Period (20 minutes) 
o Attach Markers During Warm-Up Period 
o Calibrate the System 
• Range of Motion Exercises 
o Fingers (Right and Left Hand Gathered Independently) 
§ Metacarpophalangeal Flexion and Extension 
• Perform Once 
• Gather Temperature 
• Gather Pain 
• Repeat twice (3 exercises total) 
§ Proximal Interphalangeal Flexion and Extension 
• Perform Once 
• Gather Temperature 
• Gather Pain 
• Repeat twice (3 exercises total) 
o Thumb 
§ Carpometacarpal Abduction and Adduction 
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• Perform Once 
• Gather Temperature 
• Gather Pain 
• Repeat twice (3 exercises total) 
§ Metacarpophalangeal Flexion and Extension 
• Perform Once 
• Gather Temperature 
• Gather Pain 
• Repeat twice (3 exercises total) 
• Remove Markers 
• Arthritis Hand Function Test 
o Grip Strength  
§ Perform for Right Hand 
§ Gather Temperature 
§ Gather Pain 
§ Gather Blood Oxygen Level 
§ Repeat for Left Hand 
o Pinch Strength (2-point) 
§ Perform for Right Hand 
§ Gather Temperature 
§ Gather Pain 
§ Gather Blood Oxygen Level 
§ Repeat for Left Hand 
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o Pinch Strength (3-point) 
§ Perform for Right Hand 
§ Gather Temperature 
§ Gather Pain 
§ Gather Blood Oxygen Level 
§ Repeat for Left Hand 
o Pegboard Dexterity  
§ Perform for Right Hand 
§ Gather Temperature 
§ Gather Pain 
§ Gather Blood Oxygen Level 
§ Repeat for Left Hand 
o Shoe Lacing 
§ Gather Temperature for Both Hands 
§ Gather Pain for Both Hands 
§ Gather Blood Oxygen Level for Both Hands 
o Button Board 
§ Gather Temperature for Both Hands 
§ Gather Pain for Both Hands 
§ Gather Blood Oxygen Level for Both Hands 
o Fasten Safety Pins 
§ Gather Temperature for Both Hands 
§ Gather Pain for Both Hands 
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§ Gather Blood Oxygen Level for Both Hands 
o Eating Utensil Dexterity 
§ Gather Temperature for Both Hands 
§ Gather Pain for Both Hands 
§ Gather Blood Oxygen Level for Both Hands 
o Pick Up Coins 
§ Perform for Right Hand 
§ Gather Temperature 
§ Gather Pain 
§ Gather Blood Oxygen Level 
§ Repeat for Left Hand 
o Lifting Weighted Tray 
§ Gather Temperature for Both Hands 
§ Gather Pain for Both Hands 
§ Gather Blood Oxygen Level for Both Hands 
o Pouring Water (Perform with Dominant Hand) 
§ Gather Temperature  
§ Gather Pain  
§ Gather Blood Oxygen Level  
• Remove Gloves 
• Gather Temperature for Both Hands 
• Cool-Down Period (20 minutes) 
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Throughout the study, all observations were recorded and the patient’s pain was 
monitored. In order to adapt to the changing light, the system was recalibrated during every 
warm-up period. This helped to prevent noise and to provide the best trial capture possible. 
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CHAPTER 4: DATA ANALYSIS 
 
4.1 Statistical Methods Used 
 
Descriptive statistics were used to compare the differences between the means of the 
three different interventions (placebo, IMAK Arthritis Gloves, and Veturo Therapy Infrared 
Gloves) and the mean of the control. These statistics, such as mean and standard deviation, allow 
for statistical and visual representations of the variations in the data results [52, 53]. Although a 
power analysis was not done before this pilot study, it was completed after for the use of future 
studies and can be found in later chapters. 
4.2 Personal History Survey and Pain Catastrophizing Scale 
4.2.1 Personal History Survey 
 
The results of the personal history survey (Chapter 5.1.1) were used to gain insight into 
the activities of daily ling affected by rheumatoid arthritis for each patient along with their 
overall health and well-being. Descriptive statistics was performed on the ages of participants.  
4.2.2 Pain Catastrophizing Scale 
 
The scores of each patients’ Pain Catastrophizing Scale (Chapter 5.1.2) were summed 
overall (questions 1-13) and then based on each subset; rumination (questions 8 – 11), 
magnification (questions 6, 7, 13), and helplessness (questions 1-5, 12). These scores were then 
converted into percentiles using the PCS Manual and evaluated based on the percentile (i.e. 
someone scoring in the 75th percentile overall catastrophizes their pain more than 75% of the 
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population) [3]. The mean and standard deviation of the overall summation, rumination 
summation, magnification summation, and helplessness summations were calculated in addition 
to the conversion to percentiles using the PCS Manual.  
4.3 Arthritis Hand Function Test 
 
The tasks within the Arthritis Hand Function Test were measured using an adapted 
sphygmomanometer (mm Hg), pinch meter (kg), stopwatch (seconds), weight (ounces in the 
form of number of soup cans), and volume (quarts). The average scores within each task were 
analyzed based on the AHFT worksheets and categorized (severe impairment, moderate 
impairment, mild impairment, and effective) appropriately. In addition, descriptive statistics of 
the measurements were analyzed to further compare the four groups. 
4.4 Range of Motion 
 
The range of motion tasks were recorded using the Vicon Nexus Motion Capture System. 
This data was then transferred to the C-Motion Visual 3D Motion Analysis Software where the 
joint angles were calculated based on the position of certain markers relative to others in each 
frame. The maximum joint angles reached were identified and compared to known maximum 
angles for the same range of motion exercises. The mean and standard deviation of the maximum 
joint angles was also calculated in order to provide added information when comparing the 
orthoses to the placebo glove and the control group (Table 6). 
 
 
 
 
  37 
Table 6: Range of Motion Descriptive Statistics (Angular Degrees) 
  Right Hand Left Hand 
  Control Placebo IMAK Veturo Control Placebo IMAK Veturo 
Meta.1 
Mean 85.5 84.9 84.7 85.7 86.5 85.8 86.6 86.8 
Standard 
Deviation 1 0.9 1.3 0.8 1 0.9 0.9 0.8 
Prox.2 
Mean 92.9 92 90.7 92 94.4 93.3 93.6 94.6 
Standard 
Deviation 1.9 1.8 4.1 2.1 1.1 0.9 1 1 
Carp.3 
Mean 52 51 51.2 52.1 55.4 54.6 54.9 55.7 
Standard 
Deviation 1.6 1.5 1.9 1.7 1.5 1.2 1.7 1.9 
Meta.4 
Mean 76.7 75.9 76.5 77 77.1 76.1 76.7 77.2 
Standard 
Deviation 1.3 1 1 0.9 1.5 1.1 1.1 1.1 
1 Finger Metacarpophalangeal Flexion and Extension 
2 Finger Proximal Interphalangeal Flexion and Extension 
3 Thumb Carpometacarpal Abduction and Adduction 
4 Thumb Metacarpophalangeal Flexion and Extension 
4.5 Rheumatoid Arthritis Pain Scale 
 The self-reported scores of the RAPS were recorded after the completion of each task 
within the AHFT and each range of motion exercise. The average scores of each task or 
movement were analyzed using descriptive statistics in order to further compare the four groups; 
control, placebo, IMAK, and Veturo. 
4.6 Additional Outcome Measures  
 
Temperature was recorded using a laser thermometer (°F) and the blood oxygen level 
was recorded using a pulse oximeter (%). The palm temperature was recorded after each task 
within the AHFT and each exercise of the ranges of motion. The blood oxygen level was 
recorded after each task within the AHFT only. The mean and standard deviation of the recorded 
palm temperatures and blood oxygen levels were calculated to compare the differences between 
the four groups tested.  
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CHAPTER 5: RESULTS 
5.1 Personal History and Pain Catastrophizing Scale  
5.1.1 Personal History Survey 
 
Patients were first given a personal history survey which included an adaptation of the 
Health Assessment Questionnaire (HAQ) developed and validated by Stanford University [2]. 
The tabulated results can be seen in Table 7 below.  
 
Table 7: Personal History Survey Patient Demographics 
 Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 
Gender F F F F F 
Age 56 60 68 69 36 
Year of 
Diagnosis 2017 2013 2015 2002 2017 
Medications 
Methotrexate, 
Folic Acid, 
Hydroxychloroq
uine 
Enbrel, 
Methotrexate 
Methotrexate, 
Rituxan 
Methotrexate, 
Plaquenil, 
Vitamin D, 
Turmeric, Folic 
Acid 
Plaquenil, 
Diclofenac 
Orthosis Wrist Brace None None None None 
0 - 
10 
Normal 
Daily 
Pain 
3.5 3 4 4 3 
Most 
Severe 
Pain 
5 10 6 8 9 
Least 
Severe 
Pain 
2 1 1 2 2 
Began With Idiopathic Tick Bite Muscle Disease Car Accident Car Accident 
Affects 
Fingers, Hands, 
Wrists, Neck, 
Back, Toes 
Fingers, Hands, 
Elbows, 
Shoulders, 
Toes, Feet, 
Ankles 
Fingers, Feet, 
Ankles, Knees 
Fingers, Hands, 
Wrists, 
Shoulders, 
Neck, Toes, 
Feet, Ankles, 
Knees 
Fingers, Hands, 
Wrists, Toes, 
Feet, Ankles, 
Knees, Hips 
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Table 7: Continued 
 
Blood Tests 
Negative Rf, 
Anti-CCP, 
HLA-DR4 
Positive Rf 
factor, Anti-
CCP 
NA Positive Rf Factor 
Positive Rf factor, 
Anti-CCP 
Diagnosed 
By MD* MD* MD* MD* MD* 
0
-
6 
Dress 
Yourself 2 0 0 0 0 
Shampoo 
Hair 0 0 0 2 0 
Stand Up 
from A 
Chair 
0 2 4 4 0 
Get In and 
Out of Bed 0 2 2 2 0 
Cut Your 
Meat 4 0 0 4 2 
Lift A Full 
Glass to 
Your 
Mouth 
2 0 2 0 2 
Open A 
New Milk 
Carton 
4 0 2 2 0 
Walk 
Outdoors 
on Flat 
Ground 
0 0 0 0 2 
Climb 5 
Steps 0 0 4 2 2 
Go Down 
5 Steps 0 0 4 2 2 
Walk on 
Uneven 
Ground 
0 0 2 4 2 
Assistive 
Technology 
Used 
Aids for 
Dressing None None None Cane 
Need Help 
to Complete None None None Arising None 
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Table 7: Continued 
 
0
-
6 
Wash and 
Dry Your 
Body 
2 0 0 0 0 
Take a Tub 
Bath 0 0 6 6 4 
Get On/Off 
the Toilet 0 0 4 4 2 
Reach Up 
to Get a 
5lb Bag 
4 2 2 4 4 
Bend 
Down to 
Pick Up 
Clothes 
0 0 2 2 2 
Open Car 
Doors 2 0 0 0 0 
Open 
Previously 
Opened 
Jars 
4 2 0 2 6 
Turn 
Faucets 
On/Off 
0 0 0 4 0 
Run 
Errands 2 0 2 0 2 
Get In/Out 
of Car 0 0 2 0 2 
Do Chores 6 2 2 6 6 
Dance 0 0 4 2 0 
Swim 0 0 2 2 2 
Assistive 
Technology Jar Opener 
Raised Toilet 
Seat Bathtub Bar 
Raised toilet 
seat, bathtub 
bar, handled 
appliances for 
reach 
Bathtub Seat, Jar 
opener 
Need Help 
to Complete Grip None None Reach Grip activities 
Overall 
Health Very Good Very Good Fair Very Good Very Good 
Morning 
Stiffness Yes Yes Yes Yes Yes 
Length of 
Stiffness 15 minutes 30 minutes 15 minutes 3 minutes 2 hours 
Pain the 
Week Prior 
to Testing 
(0-100) 
70 25 40 30 45 
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Table 7: Continued 
 
Morning 
Ache Yes Yes Yes Yes Yes 
Length of 
Ache 20 minutes All Day 15 minutes 30 minutes 2 hours 
Take 
Anything for 
Ache/Pain 
Yes Yes Yes No Yes 
If Yes, What Tylenol Advil Tramadol NA Diclofenac 
Fever      
Dizziness   This month  This week, this month 
Tiredness  This week This week  Today, this week, this month 
Blurred 
Vision 
Today, this 
week, this 
month 
This week   This week, this month 
Ringing in 
Ears 
Today, this 
week, this 
month 
Today   This week, this month 
Hearing 
Difficulties    This month  
Mouth Sores This month     
Dry Mouth  Today    
Loss/Change 
in Taste      
Headache This month This week This month  This week, this month 
Chest Pain      
Shortness of 
Breath  This month 
This week, this 
month   
Wheezing      
Joint Pain 
Today, this 
week, this 
month 
Today 
Today, this 
week, this 
month 
This month Today, this week, this month 
Joint 
Swelling 
Today, this 
week, this 
month 
This week This week This month Today, this week, this month 
Leg/Ankle 
Swelling     
This week, this 
month 
Low Back 
Pain 
Today, this 
week, this 
month 
 This week, this month  This month 
Muscle Pain 
Today, this 
week, this 
month 
 
Today, this 
week, this 
month 
This month This month 
Neck Pain 
Today, this 
week, this 
month 
   This month 
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Table 7: Continued 
 
Weakness of 
Muscles   
Today, this 
week, this 
month 
 This week, this month 
Loss of 
Appetite      
Nausea     This week, this month 
Heartburn 
Today, this 
week, this 
month 
 
Today, this 
week, this 
month 
This month This week, this month 
Indigestion     This week, this month 
Pain in 
Stomach 
Area 
    This week, this month 
Liver 
Problems      
Lower 
Abdomen 
Pain 
     
Diarrhea      
Constipation 
Today, this 
week, this 
month 
    
Black/Tarry 
Stool      
Vomiting      
Sadness  This month   This week 
Depression  This month  This month This week 
Insomnia This month This month   This week 
Nervousness  This month   This week 
Trouble 
Thinking  This month   
Today, this 
week, this 
month 
Easy 
Bruising 
Today, this 
week, this 
month 
    
Hives/Welts      
Itching      
Rash    This month  
Pregnancy No No No No No 
Breakfast Light Light Light Light Hearty 
Snack Before 
Lunch No No Yes Yes No 
Lunch Light Light Light Light Light 
Snack Before 
Dinner Yes No No Yes Yes 
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Table 7: Continued 
 
Dinner Hearty Hearty Light Light Light 
Snack Before 
Bed Yes Yes Yes Yes Yes 
Vegetables Conventional Conventional Conventional Conventional Conventional, Organic 
Fruits Conventional Conventional Conventional Organic Conventional, Organic 
Protein Conventional Organic Conventional Conventional Conventional, Organic 
Raw Nuts      
Almonds Yes   Yes  
Roasted Nuts  Yes   Yes 
Fats   Yes   
Olive Oil Yes Yes   Yes 
Butter Conventional Conventional Conventional  Conventional 
Salt Sea, Table Sea  Table Table 
Oil Vegetable   Fish Vegetable 
Fried Food   Yes Yes  
Changing Begin exercising None None Eating Habits None 
Glasses of 
Water Per 
Day 
3 8 4 4 12 
Type of 
Water Bottled Bottled, Filtered Bottled Bottled Tap, Filtered 
Exercise 
Frequency Monthly Weekly None Daily Weekly 
Exercises Gardening, Stationary Bike Water exercises None Walk 
Yoga, 
Gardening, 
Weights 
*MD = Rheumatologist 
 
 
As seen in Table 7 above, all subjects were female and had their rheumatoid arthritis 
diagnosed by a Rheumatologist. The average age of all participants was 57.8 years ± 13.3 years 
with individual ages ranging from 36 to 69. Four participants self-diagnosed the event that 
caused their RA symptoms to begin. The most frequent self-reported cause was a car accident (2) 
with the other two stemming from a muscular disease and a tick bite. One patient related that 
their RA was idiopathic. Additionally, all subjects were right hand dominant.  
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Within the personal history survey, participants indicated that in spite of the numerous 
activities of daily living affected by their RA (63 out of 120), four of the five patients self-
reported that they were in “very good” health and that their RA affects them, on average, 53% of 
the time. Patients also self-reported that they were affected by other health factors, such as 
heartburn and mouth sores, 32% of the time.  
5.1.2 Pain Catastrophizing Scale 
 
This scale was used to determine the psychological mindset of each patient with regards 
to pain, specifically the pain they experience related to their rheumatoid arthritis. The summary 
of each patient and the average responses of all patients can be seen below in Figure 12. The 
scale has a minimum rating of 0 and a maximum rating of 4. 
 
 
 
Figure 12: Pain Catastrophizing Scale Results 
 
As seen in the above Figure 12, the highest patient reported score was a 3 to question 1. 
This statement, “I worry all the time about whether the pain will end”, was assigned a 3 
correlating to the patient agreeing “to a great degree” [3]. The highest average score also 
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correlated to question 1 but was a 1.8. This score is between 1, “to a slight degree”, and 2, “to a 
moderate degree” [3]. The mode score was 0, answered 30 times by all 5 patients, accounting for 
46% of the self-reported answers. The spread of the self-reported scores can be seen below, in 
Table 7 and Figure 13. 
 
Table 8: Frequency of Self-Reported Scores to the PCS 
Self-Reported Score Frequency 
0 – “not at all” 30 
1 – “to a slight degree” 22 
2 – “to a moderate degree” 12 
3 – “to a great degree” 1 
4 – “all the time” 0 
 
 
 
 
Figure 13: Frequency of Self-Reported Scores to the PCS 
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Figure 14: Overall PCS Scores of Patients 
 
 In the above Figure 14 Overall PCS Scores of Patients it can be seen that the highest 
cumulative score was 20, this equates to the 50th percentile of patients (Table 5.4 PCS Score 
Percentiles) meaning that this patient is in the 50th percentile of people with respect to 
catastrophizing their pain. On the other hand, the lowest overall score was 1, which falls under 
the 4th percentile of pain catastrophizing. This is interpreted such that the highest scoring patient 
catastrophizes their pain more than 50% of people who experience pain on a daily basis while the 
lowest scoring patient catastrophizes their pain more than only 4% of people.  
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Figure 15: PCS Subscale Scores of Patients 
 
 The PCS is divided into three subscales; rumination, magnification, and helplessness [3]. 
These subscales are meant to allow interpreters to pinpoint the most hindering mentality and to 
use identify areas of influence. Magnification was determined to be the leading cause of pain 
catastrophizing within these participants, with the average subscale score corresponding to the 
50th percentile, while the average rumination fell into the 19th percentile and helplessness fell into 
the 36th. The highest subscale score of an 11 in the helplessness category is ranked in the 64th 
percentile, while the lowest of 0 in both the rumination and magnification subsets ranked in the 
3rd and 14th percentiles respectively. The associated percentiles of the overall scores and the 
subsets can be seen in Table 9.  
 
 
 
 
5
2
0
4
2
3
4
1
0
4 4
3
11
5
1
4
2
5
0
2
4
6
8
10
12
1 2 3 4 5 AVERAGE
C
at
eg
or
ic
al
 S
co
re
s
PCS Subscales of Patients
Rumination
Magnification
Helplessness
  48 
Table 9: PCS Score Percentiles 
 Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Average 
Overall 
Percentile 50
th 19th 4th 31st 19th 24th 
Rumination 
Percentile 31
st 13th 3rd 26th 13th 19th 
Magnification 
Percentile 63
rd 27th 14th 63rd 63rd 50th 
Helplessness 
Percentile 64
th 36th 10th 29th 16th 36th 
 
Given that the highest overall score was in the 50th percentile and the second lowest was 
in the 31st [3], it is suggested that patients who participated in the study may not be 
psychologically handicapped by their pain. This was also supported with the average overall 
score of 10 ± 7. It also implies that the self-reported pain scores of the Arthritis Hand Function 
Test and range of motion tasks may not be severely clouded by the psychological aspect of pain. 
5.2 Arthritis Hand Function Test 
5.2.1 Grip Strength 
 
The grip strength was measured using an adapted sphygmomanometer where the patient 
is instructed to grasp the cuff, beginning at 20mm Hg, and squeeze as strongly as possible, first 
with their right hand and then with their left. This test was performed once during each trial.  
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Figure 16: Grip Strength Image  
 
As seen in the below Figure 18 and Table 10, the average scores of all subjects were 
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. All 
patients were categorized as severely impaired (score of 100 mm Hg or less) when performing 
the task with the IMAK. Subjects were collectively categorized as having moderate impairment 
(100 mm Hg – 150 mm Hg) with the control, placebo, and Veturo gloves. Within the left hand, 
the Veturo gloves scored slightly higher within the moderate impairment category. This was the 
only instance where a glove scored higher than the control during the grip strength test. Based on 
these results, the data implies that there may be severe to moderate impairment when using the 
gloves and that there is likely no advantage to performing grip strength tasks with the gloves.  
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Figure 17: Average Grip Strength for All Subjects (mm Hg) 
 
Table 10: Hand Function Profile - Grip Strength (mm Hg) 
 Severe 
Impairment 
Moderate 
Impairment 
Mild Impairment Effective 
Right Hand I C, P, V   
Left Hand I C, P, V   
  100  150 200 
 C= Control, P = Placebo, I = IMAK, V= Veturo  
5.2.2 2-Point Pinch Strength 
 
The 2-point pinch strength was measured using a pinch meter where the patient was 
instructed to use their index finger and thumb to squeeze as strongly as they could, first with 
their right hand and then with their left. This test was performed once during each trial.  
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Figure 18: 2-Point Pinch Strength Images 
 
As seen in the below Figure 21 and Table 11, the average scores of all subjects were 
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. During 
the right hand portion, the IMAK and Veturo gloves were classified as causing mild impairment 
(2.5 kg – 5 kg) while the control and placebo glove were categorized as being effective (5kg or 
higher). This was not the case for the left hand portion, where all four groups were classified as 
being effective (5 kg or higher). Based on these results, the data suggests that the use of orthoses 
in the non-dominant hand may be beneficial when performing the 2-point pinch strength task.  
 
 
 
 
  52 
 
 
Figure 19: Average 2-Point Pinch Strength for All Subjects (kg) 
 
Table 11: Hand Function Profile - 2-Point Pinch Strength (kg) 
 Severe 
Impairment 
Moderate 
Impairment 
Mild Impairment Effective 
Right Hand   I, V C, P 
Left Hand    C, P, I, V 
  1.0  2.5 5.0 
 C= Control, P = Placebo, I = IMAK, V= Veturo  
 
5.2.3 3-Point Pinch Strength 
 
The 3-point pinch strength was measured using a pinch meter where the patient was 
instructed to use their index finger, middle finger and thumb to squeeze as strongly as possible, 
first with their right hand and then with their left. This test was performed once during each trial.  
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Figure 20: 3-Point Pinch Strength Images 
 
As seen in the below Figure 21 and Table 12, the average scores of all subjects were 
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. The 
right hand showed that all but the IMAK gloves were considered to be effective (5 kg or higher). 
While the left hand produced results that were all categorized as being effective or causing no 
impairment (5kg or higher). This information implies that the IMAK orthoses may cause a mild 
impairment when used on the dominant hand but could be effective when used on the non-
dominant hand.  
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Figure 21: Average 3-Point Pinch Strength for All Subjects (kg) 
 
Table 12: Hand Function Profile - 3-Point Pinch Strength (kg) 
 Severe 
Impairment 
Moderate 
Impairment 
Mild Impairment Effective 
Right Hand   I C, P, V 
Left Hand    C, P, I, V 
  2.0  3.5 5.0 
 C= Control, P = Placebo, I = IMAK, V= Veturo  
5.2.4 Pegboard Dexterity 
 
Pegboard dexterity was tested using a 9-hole pegboard where the patient was instructed 
to input all pegs into holes on the pegboard and then remove them as quickly as possible. Each 
patient was specifically instructed to use their index finger and thumb to pick up individual pegs 
off the table and place them in a hole, and when finished, remove all pegs as quickly as they can. 
Patients performed this test first with their right hand and then with their left. This test was 
performed once during each trial.  
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Figure 22: Pegboard Dexterity Images 
 
As seen in the below Figure 23 and Table 13, the average scores of all subjects were 
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. Both the 
right and left hand showed that the control and placebo were effective (22 seconds or less) and 
did not impair the user’s ability to perform the pegboard test. However, the IMAK and Veturo 
orthoses were classified as mildly impairing (22 seconds – 25 seconds) the user and their ability 
to complete the task as quickly as they can. Based on this data, it can therefore be suggested that 
there may be a slightly mild impairment when using the orthoses to complete the pegboard 
dexterity test.  
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Figure 23: Average Pegboard Dexterity Time for All Subjects (Seconds) 
 
Table 13: Hand Function Profile - Pegboard Dexterity (Seconds) 
 Severe 
Impairment 
Moderate 
Impairment 
Mild Impairment Effective 
Right Hand   I, V C, P 
Left Hand   I, V C, P 
  28 25 22 
 C= Control, P = Placebo, I = IMAK, V= Veturo  
5.2.5 Shoe Lacing 
 
Shoe lacing was tested using a single shoe and shoelace where the patient was instructed 
to lace the shoe as quickly as possible. This test is bimanual and was performed once during each 
trial.  
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Figure 24: Shoe Lacing Images 
 
As seen in the below Figure 25 and Table 14, the average scores of all subjects were 
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. The 
control was classified as causing mild impairment (32 seconds – 38 seconds), whereas the 
placebo was categorized as causing moderate impairment (38 seconds – 44 seconds) to the user. 
The IMAK and Veturo gloves fell under the causing severe impairment category (44 seconds and 
higher). This data suggests that the use of orthoses could cause a disadvantage when used to lace 
a shoe.  
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Figure 25: Average Shoe Lacing Time for All Subjects (Seconds) 
 
Table 14: Hand Function Profile - Shoe Lacing (Seconds) 
Severe 
Impairment 
Moderate 
Impairment 
Mild Impairment Effective 
V, I P C  
44 38 32 
C= Control, P = Placebo, I = IMAK, V= Veturo 
5.2.6 Button Board 
 
The button board test was performed using a traditional therapy button board where the 
patient was instructed to button and unbutton the entire board (4 buttons) as quickly as possible. 
This test is bimanual and was performed once during each trial.  
 
37
42
45
50
0
10
20
30
40
50
60
70
80
Se
co
nd
s
Shoe Lacing
Control
Placebo
IMAK
Veturo
  59 
    
 
Figure 26: Button Board Images 
 
As seen in the below Figure 27 and Table 15, the average scores of all subjects were 
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. Both the 
control and placebo were categorized as effective (23 seconds or less) while the IMAK and 
Veturo orthoses were classified as causing mild impairment (23 seconds – 35 seconds) to the 
user. Both the IMAK and Veturo scores were very close to the 23-second cutoff; the average 
being 24 seconds for each glove. Therefore, the data alludes to a possibility that the IMAK and 
Veturo orthoses may cause a slight mild impairment that may or may not be seen when 
compared to performing the button board task without the aid of an orthosis.  
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Figure 27: Average Button Board Time for All Subjects (Seconds) 
 
Table 15: Hand Function Profile - Button Board (Seconds) 
Severe 
Impairment 
Moderate 
Impairment 
Mild Impairment Effective 
  I, V C, P 
47 35 23 
C= Control, P = Placebo, I = IMAK, V= Veturo 
5.2.7 Safety Pin Fastening 
 
The safety pin fastening test was performed using two safety pins and a piece of folded 
cloth where the subject was instructed to fasten both safety pins into the cloth as quickly as 
possible. This test is bimanual and was performed once during each trial.  
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Figure 28: Safety Pin Fastening Images 
 
As seen in the below Figure 29 and Table 16, the average scores of all subjects were 
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. The 
control and IMAK gloves were categorized as causing mild impairment (15 seconds – 19 
seconds) while the placebo was classified as causing moderate impairment (19 seconds – 23 
seconds) and the Veturo orthoses were classified as causing severe impairment (23 seconds or 
higher). Therefore, the data suggests that the IMAK orthoses may cause the same amount of 
impairment as if the user was not using an orthosis.  
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Figure 29: Average Safety Pin Fastening Time for All Subjects (Seconds) 
 
Table 16: Hand Function Profile - Safety Pin Fastening (Seconds) 
Severe 
Impairment 
Moderate 
Impairment 
Mild Impairment Effective 
V P C, I  
23 19 15 
C= Control, P = Placebo, I = IMAK, V= Veturo 
5.2.8 Cutting Putty 
 
The cutting putty test was performed using therapeutic putty and eating utensils. The 
subject was instructed to cut along two lines down to the plate as quickly as possible. This test is 
bimanual and was performed once during each trial.  
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Figure 30: Cutting Putty Images 
 
As seen in the below Figure 31 and Table 17, the average scores of all subjects were 
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. All four 
trials were considered to be severely impaired (28 seconds or higher) with the scores of the 
orthoses being much higher than those of the control and placebo. Therefore, the data suggests 
that although the control is classified as severely impaired (28 seconds or higher), the use of the 
orthoses may not aid the user when cutting putty. 
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Figure 31: Average Cutting Putty Time for All Subjects (Seconds) 
 
Table 17: Hand Function Profile - Cutting Putty (Seconds) 
Severe 
Impairment 
Moderate 
Impairment 
Mild Impairment Effective 
C, P, I, V    
28 23 18 
C= Control, P = Placebo, I = IMAK, V= Veturo 
5.2.9 Picking Up Coins 
 
The coin pickup test was performed using four coins (1 penny, 1 nickel, 1 dime, and 1 
quarter) and a change box. The subject was instructed to pick up one coin at a time and place it 
into the slotted change box as quickly as possible, first with their right hand and then with their 
left. This test was performed once during each trial.  
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Figure 32: Coin Pickup Images 
 
As seen in the below Figure 33 and Table 18, the average scores of all subjects were 
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. All trials 
were categorized as effective (11 seconds or less) with the Veturo gloves scoring slightly better 
than the other groups in the right hand. Although the orthoses were classified as effective (11 
seconds or less) for the left hand, they were shown to be slightly higher than the control. 
Therefore, the data suggests that the use of the Veturo gloves in the dominant hand may be 
beneficial to the user while the use of either orthoses in the non-dominant hand may not provide 
any assistance when picking up coins.  
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Figure 33: Average Coin Pickup Time for All Subjects (Seconds) 
 
Table 18: Hand Function Profile - Coin Pickup (Seconds) 
 Severe 
Impairment 
Moderate 
Impairment 
Mild Impairment Effective 
Right Hand    C, P, I, V 
Left Hand    C, P, I, V 
  15 13 11 
C= Control, P = Placebo, I = IMAK, V= Veturo 
5.2.10 Lifting Cans 
 
The lifting cans test was performed using 12 soup cans (10.5oz each) and a tray. The 
weighted tray was placed on a table in front of the subject who was then instructed to lift the 
weighted tray straight up while remaining seated. The max weight was determined by placing 
one additional can at a time onto the tray and asking the patient if they felt like they could lift 
more after performing the motion. This test is bimanual and was performed once during each 
trial.  
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Figure 34: Lifting Cans Images 
 
As seen in the below Figure 35 and Table 19, the average scores of all subjects were 
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. The 
control was classified as causing mild impairment (less than 12 cans but more than 9) while the 
placebo, IMAK and Veturo orthoses were categorized as effective (12 cans). Therefore, the data 
suggests that using orthoses while lifting a weighted tray may provide some additional aid.  
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Figure 35: Average Lifting Cans Test for All Subjects (Number of Cans) 
 
Table 19: Hand Function Profile - Lifting Cans (Number of Cans) 
Severe 
Impairment 
Moderate 
Impairment 
Mild Impairment Effective 
  C P, I, V 
6 9 12 
C= Control, P = Placebo, I = IMAK, V= Veturo 
5.2.11 Pouring Water 
 
The pouring water test was performed using a 2-quart pitcher and a cup. The subject was 
instructed to lift the pitcher off the table with their dominant hand and pour water into the cup. If 
they were unable to do so water would be taken out of the pitcher until the subject could lift it. 
This test is bimanual and was performed once during each trial.  
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Figure 36: Pouring Water Images 
 
As seen in the below Figure 37 and Table 20, the average scores of all subjects were 
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. All trials 
were classified as effective (2 quarts) as no subjects were unable to lift the full 2-quart pitcher. 
As there was no difference in the scores, the data suggests that there is no advantage or 
disadvantage to using orthoses when performing the pouring water test.  
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Figure 37: Average Pouring Water Test for All Subjects (Quarts) 
 
Table 20: Hand Function Profile - Pouring Water (Quarts) 
Severe 
Impairment 
Moderate 
Impairment 
Mild Impairment Effective 
   C, P, I, V 
1 1.5 2 
C= Control, P = Placebo, I = IMAK, V= Veturo 
5.3 Range of Motion 
 
The following range of motion exercises were performed using the control, placebo, 
IMAK, and Veturo orthoses. The maximum joint angles of each movement were compared for 
statistical significance.  
5.3.1 Finger Metacarpophalangeal Flexion and Extension  
 
Finger Metacarpophalangeal flexion and extension was performed 3 times with each 
group for a total of 12 flexion/extensions per participant. Subjects were given a picture 
representation (Appendix C) of the movement along with a demonstration and then asked to 
perform to the best of their abilities. 
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Figure 38: Metacarpophalangeal Flexion and Extension Images 
 
   
 
Figure 39: Finger Metacarpophalangeal Flexion and Extension (Vicon) Images 
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Figure 40: Average Finger Metacarpophalangeal Flexion and Extension (Right Hand) 
 
 
  
 
Figure 41: Average Finger Metacarpophalangeal Flexion and Extension (Left Hand) 
 
As seen in the above Figures 40 and 41, the average joint angles for the finger 
metacarpophalangeal flexion and extension of the right and left hand are shown. Within each 
hand, there was no little difference between the maximum joint angles reached between 
intervention groups and the control. Therefore, the data suggests that the use of the orthoses may 
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not increase or decrease the maximum joint angle when performing metacarpophalangeal flexion 
and extension. 
5.3.2 Finger Proximal Interphalangeal Flexion and Extension 
 
Finger Proximal Interphalangeal flexion and extension was performed 3 times with each 
group for a total of 12 flexion/extensions per participant. Subjects were given a picture 
representation (Appendix C) of the movement along with a demonstration and then asked to 
perform to the best of their abilities. 
    
 
Figure 42: Finger Proximal Interphalangeal Flexion and Extension Images 
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Figure 43: Finger Proximal Interphalangeal Flexion and Extension (Vicon) Images 
 
  
 
Figure 44: Average Finger Proximal Interphalangeal Flexion and Extension (Right Hand) 
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Figure 45: Finger Proximal Interphalangeal Flexion and Extension (Left Hand) 
 
As seen in the above Figures 44 and 45, the average joint angles for the finger proximal 
interphalangeal flexion and extension of the right and left hand are shown. Within each hand, 
little to no difference between the maximum joint angles reached between intervention groups 
and the control were seen. Therefore, this data implies that the use of the orthoses may not 
increase or decrease the maximum joint angle when performing proximal interphalangeal flexion 
and extension. 
5.3.3 Thumb Carpometacarpal Abduction and Adduction 
 
Thumb Carpometacarpal abduction and adduction was performed 3 times with each 
group for a total of 12 abduction/adductions per participant. Subjects were given a picture 
representation (Appendix C) of the movement along with a demonstration and then asked to 
perform to the best of their abilities. 
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Figure 46: Thumb Carpometacarpal Abduction and Adduction Images 
 
   
 
Figure 47: Thumb Carpometacarpal Abduction and Adduction (Vicon) Images 
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Figure 48: Average Thumb Carpometacarpal Abduction and Adduction (Right Hand) 
 
  
 
Figure 49: Average Thumb Carpometacarpal Abduction and Adduction (Left Hand) 
 
As seen in the above Figures 48 and 49, the average joint angles for the thumb 
carpometacarpal abduction and adduction of the right and left hand are shown. Within each hand, 
there was no little to no difference between the maximum joint angles reached between 
intervention groups and the control. This data therefore implies that the use of the orthoses may 
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not increase or decrease the maximum joint angle when performing thumb carpometacarpal 
abduction and adduction. 
5.3.4 Thumb Metacarpophalangeal Flexion and Extension 
 
Thumb Metacarpophalangeal flexion and extension was performed 3 times with each 
group for a total of 12 flexion/extensions per participant. Subjects were given a picture 
representation (Appendix C) of the movement along with a demonstration and then asked to 
perform to the best of their abilities. 
     
 
Figure 50: Thumb Metacarpophalangeal Flexion and Extension Images 
 
     
Figure 51: Thumb Metacarpophalangeal Flexion and Extension (Vicon) Images 
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Figure 52: Average Thumb Metacarpophalangeal Flexion and Extension (Right Hand) 
 
  
 
Figure 53: Average Thumb Metacarpophalangeal Flexion and Extension (Left Hand) 
 
As seen in the above Figures 52 and 53, the average joint angles for the thumb 
metacarpophalangeal flexion and extension of the right and left hand are shown. Within each 
hand, there was little to no difference between the maximum joint angles reached between 
intervention groups and the control. Therefore, this information implies that the use of the 
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orthoses may not increase or decrease the maximum joint angle when performing thumb 
metacarpophalangeal flexion and extension. 
5.4 Rheumatoid Arthritis Pain Scale 
5.4.1 Arthritis Hand Function Test 
 
After each task was completed, subjects were asked to rate the pain they experienced 
while performing the task using the Rheumatoid Arthritis Pain Scale [10]. The following figures 
and results are the findings of the pain associated with each task of the Arthritis Hand Function 
Test.  
5.4.1.1 Grip Strength Pain 
 
As seen in the below Figure 54, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. On average, the 
dominant, right, hand experienced more pain (3 ±2) than the non-dominant, left, hand (2 ±2). As 
seen in the right hand, the difference between the pain experienced when performing the grip 
strength task with the control versus the IMAK was 2 while the difference between the control 
and Veturo was 1. Alternately, the IMAK performed worse than the control in the left hand 
(difference of 1) while the Veturo performed as well as the control and placebo. This data 
suggests that there might be an advantage to using the IMAK or Veturo in the dominant hand 
while there might not be an advantage in the non-dominant hand.  
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Figure 54: Average Pain for Grip Strength 
5.4.1.2 2-Point Pinch Strength Pain 
 
As seen in the below Figure 55, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The control, 
IMAK and Veturo gloves all scored on average a 2 (±1) in the right hand while the placebo 
averaged 3 (±2). The orthoses remained the same (2 ±1) in the left hand while the averages of the 
control and placebo both decreased. This data implies that the use of the IMAK or Veturo 
orthoses may not provide an advantage when performing the 2-point pinch strength test. 
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Figure 55: Average Pain for 2-Point Pinch Strength 
5.4.1.3 3-Point Pinch Strength Pain 
 
As seen in the below Figure 56, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. As seen in the 
below figure, there was much more variability in the self-reported pain felt in the dominant hand 
when compared to the non-dominant hand; a difference of the lowest score to the highest score 
being 2 for the dominant (right) hand and 0 for the non-dominant (left) hand. When comparing 
within the right hand, the control was reported to cause the least amount of pain (1 ±1), the 
placebo the most amount (3 ±1), and the orthoses were both reported to cause on average a pain 
level of 2 ±1. This data suggests that the use of the IMAK or Veturo orthoses may not provide an 
advantage when used during the 3-point pinch strength with respect to pain.   
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Figure 56: Average Pain for 3-Point Pinch Strength 
5.4.1.4 Pegboard Dexterity Pain 
 
As seen in the below Figure 57, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The right and left 
hands were similar in that three of the four groups had an average reported score of 1 ±1 with 
one group averaging 2 ±1. For the right hand this single group was the placebo whereas the 
higher score of the left hand was the IMAK glove. This data suggests that the use of either 
orthosis on the dominant hand may not provide any advantage towards pain but the use of the 
IMAK on the non-dominant hand may cause a disadvantage.  
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Figure 57: Average Pain for Pegboard Dexterity 
5.4.1.5 Shoe Lacing Pain 
 
As seen in the below Figure 58, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The shoe-lacing 
task was verbally reported to be one of the more difficult tasks by multiple subjects however, the 
pain scores remain relatively low. The placebo and IMAK both had, on average, higher self-
reported scores (2 ±2) than the control and Veturo (1 ±1). This data suggests that the use of the 
IMAK gloves may increase the pain reported by users while the Veturo gloves may not provide 
any advantage for pain when performing the shoe lacing test. 
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Figure 58: Average Pain for Shoe Lacing 
5.4.1.6 Button Board Pain 
 
As seen in the below Figure 59, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The button board 
task was one of the least challenging tasks for subjects with respect to pain, keeping the self-
reported scores relatively low. The control and IMAK groups were found to be the highest with 
respect to pain (2 ±2 and 2 ±1 respectively) while the placebo and Veturo gloves were the lowest 
scoring (1 ±1). This information implies that the use of the Veturo gloves may decrease the pain 
experienced when performing the button board portion of the AHFT. 
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Figure 59: Average Pain for Button Board 
5.4.1.7 Safety Pin Fastening Pain 
 
As seen in the below Figure 60, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The average 
scores were the same for all groups (2) with slight variations in the standard deviation (control 
and placebo: ±1, IMAK and Veturo: ±2). This data suggests that the use of either orthoses may 
not help or hurt the overall pain experienced during the safety pin fastening test. 
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Figure 60: Average Pain for Fastening Safety Pins 
5.4.1.8 Cutting Putty Pain 
 
As seen in the below Figure 61, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The cutting putty 
task was arguably the most difficult for subjects with respect to pain, both through their self-
reported scores and verbal feedback when completing the task. The Veturo gloves scored the 
lowest self-reported pain scores out of all of the groups with an average of 3 (±3). This 
information implies that the use of the Veturo gloves when performing the cutting putty test may 
reduce the self-reported pain experienced by users. 
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Figure 61: Average Pain for Cutting Putty 
5.4.1.9 Picking Up Coins Pain 
 
As seen in the below Figure 62, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The right hand 
showed slight variability amongst groups with the IMAK gloves averaging 2 (±1) and the other 
groups averaging 1 (±1) whereas the left hand remained constant with all groups averaging 1 
(±1). This data suggests that the use of the IMAK gloves may increase the pain experienced 
when used in the dominant hand whereas the use of the Veturo gloves may not increase or 
decrease the pain experienced when completing the picking up coins test.  
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Figure 62: Average Pain for Picking Up Coins 
5.4.1.10 Lifting Cans Pain 
 
As seen in the below Figure 63, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. On average, the 
levels of pain reported by the subjects showed that the most amount of pain was experienced 
when using the IMAK gloves (3 ±3) while the other groups were reported to experience a level 
of 2 (±2). This suggests that the use of the IMAK gloves may increase the pain experienced 
while the use of the Veturo gloves may not increase or decrease the pain experienced. 
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Figure 63: Average Pain for Lifting Cans 
5.4.1.11 Pouring Water Pain 
 
As seen in the below Figure 64, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The self-reported 
pain experienced when pouring water was once again relatively low, with the highest being 
experienced during the IMAK intervention (2 ±1). Therefore, the data suggests that the use of the 
IMAK gloves may increase the self-reported pain experienced by users while the Veturo gloves 
may not increase or decrease the pain experienced when completing the pouring water test. 
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Figure 64: Average Pain for Pouring Water 
5.4.2 Range of Motion Tasks 
5.4.2.1 Finger Metacarpophalangeal Flexion and Extension Pain 
 
As seen in the below Figure 65 the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. Similar to 
previous results, the dominant hand (right) was reported to experience more pain than the non-
dominant (left) hand. The self-reported pain experienced while performing the finger 
metacarpophalangeal flexion and extension was relatively low with the highest scores reporting 
from the right hand during the placebo and IMAK groups (2 ±1). This data suggests that the use 
of the IMAK gloves in the dominant hand may increase pain experienced while the use of the 
Veturo in both the dominant and non-dominant hand may not increase pain experienced. 
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Figure 65: Average Pain for Finger Metacarpophalangeal Flexion and Extension 
5.4.2.2 Finger Proximal Interphalangeal Flexion and Extension Pain 
 
As seen in the below Figure 66, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. Once again, the 
pain reportedly experienced in the dominant hand was greater than the pain in the non-dominant 
hand however, both hands remain relatively low on the pain scale. Within both hands, the Veturo 
gloves were shown to have lower pain experienced (1 ±1 in the right hand and 0 ±1 in the left 
hand) when compared to the other groups. This information implies that the use of the Veturo 
gloves may decrease the self-reported pain experienced when performing finger proximal 
interphalangeal flexion and extension. 
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Figure 66: Average Pain for Finger Proximal Interphalangeal Flexion and Extension 
5.4.2.3 Thumb Carpometacarpal Abduction and Adduction Pain 
 
As seen in the below Figure 67, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The self-reported 
pain experienced when performing thumb carpometacarpal abduction and adduction was fairly 
low with a narrow range of most average scores. The IMAK gloves in the right hand were the 
only exception with an average score of 2 (±1) compared to the 1 (±1) of all other scores in both 
hands. This data suggests that the use of the IMAK gloves in the dominant hand may increase the 
pain experienced during the thumb metacarpophalangeal abduction and adduction exercises. 
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Figure 67: Average Pain for Thumb Carpometacarpal Abduction and Adduction 
5.4.2.4 Thumb Metacarpophalangeal Flexion and Extension Pain 
 
As seen in the below Figure 68, the average scores of all subjects were calculated based 
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. It can be seen that 
overall the dominant (right) hand was self-reported to cause more pain than the non-dominant 
(left) hand. In the dominant hand, the Veturo gloves were shown to cause the least amount of 
pain (1 ±1). The IMAK gloves were once again shown to be associated with the most pain in the 
non-dominant hand (2 ±1) while the Veturo gloves remained equal to the control (1 ±1). This 
information implies that the use of the Veturo gloves on the dominant hand may decrease the 
pain experienced while the use of the IMAK gloves on the non-dominant hand may increase the 
pain experienced during the thumb metacarpophalangeal flexion and extension exercise. 
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Figure 68: Average Pain for Thumb Metacarpophalangeal Flexion and Extension 
5.5 Additional Outcome Measures  
5.5.1 Temperature  
 
After each task in both the Arthritis Hand Function Test and the range of motion 
exercises, the temperature of the subject’s palm was recorded using a laser thermometer. 
Depending on the task, unilateral or bilateral, temperature was recorded on the appropriate 
hand(s).  
5.5.1.1 Arthritis Hand Function Test 
5.5.1.1.1 Grip Strength Temperature 
 
As seen in the below Figure 69, the average scores of all subjects were measured using 
the laser thermometer. The average palm temperature during the grip strength test was highest in 
the control group by a maximum of 3°F when compared to the intervention groups. The 
intervention groups all averaged a lower temperature than the control for both hands during the 
grip strength task, with the Veturo gloves lower than the IMAK in the left hand (83°F ±7°F 
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versus 84°F ±7°F). This data suggests that the use of either orthosis may not increase the palm 
temperature during the grip strength portion of the AHFT. 
 
 
 
Figure 69: Average Temperature During Grip Strength 
5.5.1.1.2 2-Point Pinch Strength Temperature 
 
As seen in the below Figure 70, the average scores of all subjects were measured using 
the laser thermometer. Similar to grip strength, 2-point pinch strength palm temperatures were 
highest during the control. The differences between the control and the intervention groups was 
most apparent with the placebo glove in the right hand (87°F ±7°F versus 84°F ±6°F) but was 
also visible between both the orthoses and the control. This information implies that the use of 
the IMAK or Veturo orthoses may decrease the palm temperature when performing the 2-point 
pinch strength task. 
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Figure 70: Average Temperature During 2-Point Pinch Strength 
5.5.1.1.3 3-Point Pinch Strength Temperature 
 
As seen in the below Figure 71, the average scores of all subjects were measured using 
the laser thermometer. The difference in palm temperature was much more visible in the left 
hand, rather than the right, during the 3-point pinch strength test. The largest difference amongst 
temperatures in the left hand was between the placebo (82°F ±6°F) and the control (86°F ±6°F). 
In both the right and left hands, the Veturo gloves were recorded to have the lowest palm 
temperature (84°F ±6°F and 83°F ±6°F respectively). This data suggests that the use of either the 
IMAK or Veturo orthoses may decrease the palm temperature during the 3-point pinch strength 
portion of the AHFT. 
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Figure 71: Average Temperature During 3-Point Pinch Strength 
5.5.1.1.4 Pegboard Dexterity Temperature 
 
As seen in the below Figure 72, the average scores of all subjects were measured using 
the laser thermometer. Similar to previous temperature results, the left hand had a slightly lower 
temperature in each group. Within the right hand, the placebo and Veturo gloves were recorded 
to have the lowest temperature (84°F ±6°F for each) while the control was recorded to have the 
highest (86°F ±7°F) followed by the IMAK (85°F ±7°F). The control remained the highest in the 
left hand (85°F ±7°F) while the placebo group had the lowest recorded average temperature 
(82°F ±6°F). The IMAK and Veturo gloves were recorded to have the same average temperature 
in the left hand; 84°F (±7°F for IMAK and ±6°F for Veturo). This data suggests that the use of 
either orthosis may decrease the palm temperature in the dominant and non-dominant hands 
when compared to the control.  
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Figure 72: Average Temperature During Pegboard Dexterity Test 
5.5.1.1.5 Shoe Lacing Temperature 
 
As seen in the below Figure 73, the average scores of all subjects were measured using 
the laser thermometer. Keeping in mind the previous temperatures of tests such as the 2-point 
pinch strength and pegboard dexterity, the variation of palm temperature remains fairly small. 
Within the shoe-lacing test, the placebo was found to have the lowest recorded temperature at 
83°F (±6°F) followed closely by the Veturo gloves at 84°F (±6°F). The control group continued 
to have the highest average temperature at 86°F (±7°F) while the IMAK averaged 85°F (±7°F). 
This information implies that while both orthoses may decrease the temperature, the use of the 
Veturo orthoses may decrease the average palm temperature more so than the IMAK. 
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Figure 73: Average Temperature During Shoe Lacing Test 
5.5.1.1.6 Button Board Temperature 
 
As seen in the below Figure 74, the average scores of all subjects were measured using 
the laser thermometer. The control group remained to be the highest recorded temperature (86°F 
±8°F) followed closely by the IMAK gloves (85°F ±7°F). The placebo and Veturo gloves 
averaged the same palm temperature of 84°F (±6°F) during the button board test. This data 
suggests that the use of either the IMAK or Veturo gloves may decrease the average palm 
temperature during the button board portion of the AHFT. 
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Figure 74: Average Temperature During Button Board Test 
5.5.1.1.7 Safety Pin Fastening Temperature 
 
As seen in the below Figure 75, the average scores of all subjects were measured using 
the laser thermometer. Similar to previous palm temperature results, the control had the highest 
recorded temperature (86°F ±8°F) followed by the IMAK gloves (85°F ±7°F). The placebo and 
Veturo gloves both averaged a palm temperature of 84°F (±7°F). This information suggests that 
the use of either the IMAK or Veturo gloves may decrease the palm temperature and possibly 
that the Veturo gloves may decrease the temperature more so than the IMAK.  
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Figure 75: Average Temperature During Safety Pin Fastening Test 
5.5.1.1.8 Cutting Putty Temperature 
 
As seen in the below Figure 76, the average scores of all subjects were measured using 
the laser thermometer. As seen previously, the control had the highest recorded temperature 
(86°F ±7°F) followed by the IMAK gloves (85°F ±8°F). The placebo and Veturo gloves both 
averaged a palm temperature of 84°F (±7°F). This information suggests that the use of either the 
IMAK or Veturo gloves may decrease the palm temperature and possibly that the Veturo gloves 
may decrease the temperature more so than the IMAK. 
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Figure 76: Average Temperature During Cutting Putty Test 
5.5.1.1.9 Picking Up Coins Temperature 
 
As seen in the below Figure 77, the average scores of all subjects were measured using 
the laser thermometer. In both the right and left hands, the control maintained an average palm 
temperature of 87°F (±6°F) and the Veturo maintained an average palm temperature of 84°F 
(±6°F). The placebo and IMAK fluctuated slightly, but the individual differences remained 
within 2°F. This data indicates that the use of either orthoses, IMAK or Veturo, may decrease the 
average palm temperature when completing the coin pick up portion of the AHFT. 
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Figure 77: Average Temperature During Picking Up Coin Test 
5.5.1.1.10 Lifting Cans Temperature 
 
As seen in the below Figure 78, the average scores of all subjects were measured using 
the laser thermometer. The palm temperatures of both hands during the lifting cans test 
continued the pattern of the control being the highest temperature (87°F ±7°F). The Veturo, 
having had the lowest temperature of 84°F (±7°F), was 3°F lower than the control. The placebo 
and IMAK averaged the same palm temperature during the lifting cans test at 86°F (±8°F and 
±7°F respectively). This information suggests that the use of either the IMAK or Veturo gloves 
may decrease the palm temperature during this portion of the AHFT. 
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Figure 78: Average Temperature During Lifting Cans Test 
5.5.1.1.11 Pouring Water Temperature 
 
As seen in the below Figure 79, the average scores of all subjects were measured using 
the laser thermometer. The pouring water test was the first instance of the IMAK gloves having 
the lowest average temperature at 84°F (±7°F). The control remained the highest average 
temperature at 86°F (±7°F) and the placebo and Veturo continued to be the same at 85°F (±8°F 
and ±5°F respectively). This data suggests that the use of either the IMAK or Veturo orthoses 
may decrease the average palm temperature while performing the pouring water test. 
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Figure 79: Average Temperature During Pouring Water Test 
5.5.1.2 Range of Motion  
5.5.1.2.1 Finger Metacarpophalangeal Flexion and Extension Temperature 
 
As seen in the below Figure 80, the average scores of all subjects were measured using 
the laser thermometer. Similar to the palm temperatures recorded during the AHFT, the control 
was the highest average temperature recorded in both the right (87°F ±5°F) and left (87°F ±5°F) 
hands. The placebo was the lowest in the right hand (84°F ±4°F) while the placebo, IMAK, and 
Veturo were equally low in the left hand. This data suggests that the use of the IMAK or Veturo 
orthoses may decrease the palm temperature during finer metacarpophalangeal flexion and 
extension. 
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Figure 80: Average Temperature During Finger Metacarpophalangeal Flexion and Extension 
5.5.1.2.3 Finger Proximal Interphalangeal Flexion and Extension Temperature 
 
As seen in the below Figure 81, the average scores of all subjects were measured using 
the laser thermometer. The differences between groups were clearly seen during the proximal 
interphalangeal flexion and extension movements. The control continued to be the highest 
temperature in both hands (88°F ±6°F and 86°F ±5°F) while the Veturo was the lowest in the left 
hand (83°F ±5°F). This information suggests that the use of the IMAK or Veturo gloves may 
decrease the palm temperature when performing proximal interphalangeal flexion and extension. 
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Figure 81: Average Temperature During Finger Proximal Interphalangeal Flexion and Extension 
5.5.1.2.4 Thumb Carpometacarpal Abduction and Adduction Temperature 
 
As seen in the below Figure 82, the average scores of all subjects were measured using 
the laser thermometer. The variations between and within each hand were visible in the below 
figure. The control continued to be the highest in each hand (87°F ±4°F and 86°F ±4°F) while 
the placebo and Veturo were the lowest (84°F ±5°F and 83°F ±4°F). The IMAK was slightly 
lower than the control and slightly above the placebo and Veturo in both hands (85°F ±5°F in the 
right and 84°F ±6°F in the left). This data suggests that the use of either the IMAK or Veturo 
orthoses may decrease the palm temperature, while the Veturo may decrease the temperature 
more than the IMAK. 
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Figure 82: Average Temperature During Thumb Carpometacarpal Abduction and Adduction 
5.5.1.2.5 Thumb Metacarpophalangeal Flexion and Extension Temperature 
 
As seen in the below Figure 83, the average scores of all subjects were measured using 
the laser thermometer. The scores follow the trend previously seen in other range of motion and 
AHFT exercises; higher control temperature and similar, lower intervention temperatures. This 
information implies that the use of the IMAK or Veturo gloves may decrease the palm 
temperature when performing metacarpophalangeal flexion and extension of the thumb. 
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Figure 83: Average Temperature During Thumb Metacarpophalangeal Flexion and Extension 
5.5.1.3 Temperature Variation 
 
The palm temperature was recorded at the beginning of each trial, after the 20-minute 
warm up period (for intervention groups), after each task or exercise, and after all tests had been 
completed. For each trial, after performing all range of motion exercises and the Arthritis Hand 
Function Test, the subjects were instructed to remove the orthosis immediately following the 
temperature recording of the last test in order to obtain the palm temperature of their skin. This 
was included because of a slight gap between the intervention material and the skin of the palm 
causing concern of accurate temperature readings. As seen below in Figure 84, for each trial 
there was an increase in the temperature recording after the last test and after removing the 
orthosis. The largest increase was seen in the Veturo, which increases from 85°F to 89°F after 
removing the gloves. This suggests that the actual palm temperature when using the Veturo 
gloves may be higher than recorded. 
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Figure 84: Average Temperature Variation Throughout Trials 
5.5.2 Blood Oxygen Levels 
 
Blood oxygen levels were measured using a pulse oximeter after each trial during the 
Arthritis Hand Function Test. Only four of the five patients’ data is included in the below results 
because only 12 of the 69 (19%) points of data were able to be collected for one of the subjects. 
The patient’s nails were too long to allow for the pulse oximeter to be placed properly on a finger 
and obtain an accurate reading.  
5.5.2.1 Grip Strength Blood Oxygen Level 
 
As seen in the below Figure 85, the average scores of all subjects included were 
calculated based on the individual blood oxygen level readings using the pulse oximeter. There 
was very little difference between the left and right hand overall, with some slight variation 
occurring in the right hand during the placebo trial. The Veturo gloves were shown to be higher 
than the control (99% ±1% versus 98% ±2%) in the left hand while both the Veturo and IMAK 
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gloves were less than the control (98% ±2% versus 99% ±1%)in the right hand. This data 
suggests that the Veturo gloves may increase the blood oxygen level in the non-dominant hand. 
 
 
  
 
Figure 85: Average Blood Oxygen Level During Grip Strength Test 
5.5.2.2 2-Point Pinch Strength Blood Oxygen Level 
 
As seen in the below Figure 86, the average scores of all subjects included were 
calculated based on the individual blood oxygen level readings using the pulse oximeter. The 
average blood oxygen level was highest in the control, IMAK, and Veturo in the right hand (98% 
±1%) and highest in the placebo and IMAK in the left hand (98% ±2%). This information 
suggests that the use of the IMAK or Veturo gloves may not increase or decrease the blood 
oxygen level in the dominant hand while the use of the IMAK gloves may increase the blood 
oxygen level in the non-dominant hand. 
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Figure 86: Average Blood Oxygen Level During 2-Point Pinch Strength Test 
5.5.2.3 3-Point Pinch Strength Blood Oxygen Level 
 
As seen in the below Figure 87, the average scores of all subjects included were 
calculated based on the individual blood oxygen level readings using the pulse oximeter. The 
placebo and IMAK gloves had a higher blood oxygen level than the control and Veturo in the 
right hand (98% ±1% versus 97% ±1%) whereas the placebo, IMAK, and Veturo gloves were all 
higher than the control in the left hand (98% ±1% versus 97% ±1%). This suggests that the use 
of the IMAK gloves may increase the blood oxygen level in both hands while the use of the 
Veturo gloves may increase the blood oxygen level in the non-dominant hand. 
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Figure 87: Average Blood Oxygen Level During 3-Point Pinch Strength Test 
5.5.2.4 Pegboard Dexterity Blood Oxygen Level 
 
As seen in the below Figure 88, the average scores of all subjects included were 
calculated based on the individual blood oxygen level readings using the pulse oximeter. The 
control and Veturo gloves were recorded to have the same average blood oxygen level (98% 
±1%) in the right hand while the placebo and IMAK gloves were 1% lower at 97% ±1%. 
Alternatively, the control and placebo were the same in the left hand (98% ±2%) while the 
IMAK gloves were recorded to be on average 97% ±2% and the Veturo gloves 96% ±4%. This 
data suggests that the use of the Veturo gloves may decrease the blood oxygen level in the non-
dominant hand while the use of the IMAK gloves may decrease the blood oxygen level in either 
hand. 
 
97 97
98 9898 98
97
98
94.5
95
95.5
96
96.5
97
97.5
98
98.5
99
99.5
Bl
oo
d 
O
xy
ge
n 
(%
)
Right Hand Left Hand
3-Point Pinch Strength Blood 
Oxygen Level
Control
Placebo
IMAK
Veturo
  115 
  
 
Figure 88: Average Blood Oxygen Level During Pegboard Dexterity Test 
5.5.2.5 Shoe Lacing Blood Oxygen Level 
 
As seen in the below Figure 89, the average scores of all subjects included were 
calculated based on the individual blood oxygen level readings using the pulse oximeter. As 
shown below, there were no differences in the average blood oxygen level during the shoe lacing 
portion of the AHFT. Therefore, this data suggests that the use of the IMAK or Veturo gloves 
may not increase or decrease the blood oxygen level during this test. 
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Figure 89: Average Blood Oxygen Level During Shoe Lacing Test 
5.5.2.6 Button Board Blood Oxygen Level 
 
As seen in the below Figure 90, the average scores of all subjects included were 
calculated based on the individual blood oxygen level readings using the pulse oximeter. Similar 
to previous tasks, the difference between the highest and lowest average blood oxygen level was 
narrow at 1%. The only group that was not at 98% ±1% was the IMAK at 97% ±1%. Therefore, 
this information implies that the use of the IMAK gloves may decrease the blood oxygen level 
while the use of the Veturo may not increase or decrease the blood oxygen level during the 
button board test. 
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Figure 90: Average Blood Oxygen Level During Button Board Test 
5.5.2.7 Safety Pin Fastening Blood Oxygen Level 
 
As seen in the below Figure 91, the average scores of all subjects included were 
calculated based on the individual blood oxygen level readings using the pulse oximeter. The 
blood oxygen level remained at 98% ±1% during the control, placebo, and IMAK groups. The 
Veturo was averaged at 97% ±2%, 1% lower than the control. This data implies that the use of 
the IMAK gloves may not increase or decrease the blood oxygen level while the Veturo gloves 
may decrease the blood oxygen level. 
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Figure 91: Average Blood Oxygen Level During Safety Pin Fastening Test 
5.5.2.8 Cutting Putty Blood Oxygen Level 
 
As seen in the below Figure 92, the average scores of all subjects included were 
calculated based on the individual blood oxygen level readings using the pulse oximeter. The 
average blood oxygen level remained constant within the control, placebo, and IMAK groups 
(98% ±2%) but increased in the Veturo group (99% ±1%). This suggests that the use of the 
Veturo gloves may increase the blood oxygen level during the cutting putty test while the use of 
the IMAK may not increase or decrease the blood oxygen level. 
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Figure 92: Average Blood Oxygen Level During Cutting Putty Test 
5.5.2.9 Picking Up Coins Blood Oxygen Level 
 
As seen in the below Figure 93, the average scores of all subjects included were 
calculated based on the individual blood oxygen level readings using the pulse oximeter. There 
was some variation when comparing the dominant (right) to the non-dominant (left) hands with 
the lowest score from the right hand at 96% ±3% and the lowest from the left at 98% ±1%. The 
IMAK was recorded as the having the lowest average blood oxygen level in the right hand (96% 
±3%) yet the highest in the left hand (99% ±1%). Additionally, the Veturo gloves were recorded 
to be lower than the control in the right hand (97% ±1% versus 98% ±1%) but equal in the left 
hand (98% ±1%). This information implies that the use of both the IMAK and Veturo gloves 
may increase or decrease the blood oxygen level during the picking up coins test. 
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Figure 93: Average Blood Oxygen Level During Coin Pickup Test 
5.5.2.10 Lifting Cans Blood Oxygen Level 
 
As seen in the below Figure 94, the average scores of all subjects included were 
calculated based on the individual blood oxygen level readings using the pulse oximeter. Similar 
to previous tests, the blood oxygen level of the control was highest at 99% ±2%. The IMAK was 
recorded to have the lowest average blood oxygen level at 97% ±0% while the Veturo and 
placebo groups were recorded as equally 98% ±1%. This data suggests that the use of the IMAK 
or Veturo orthoses may decrease the blood oxygen level during the lifting cans portion of the 
AHFT. 
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Figure 94: Average Blood Oxygen Level During Lifting Cans Test 
5.5.2.11 Pouring Water Blood Oxygen Level 
 
As seen in the below Figure 95, the average scores of all subjects included were 
calculated based on the individual blood oxygen level readings using the pulse oximeter. The 
control and placebo were recorded to have equal average blood oxygen levels at 98% ±1% while 
the IMAK gloves were recorded to have 96% ±2% and the Veturos 97% ±2%. This information 
implies that the use of the IMAK or Veturo orthoses may decrease the blood oxygen level when 
compared to the control in the pouring water portion of the AHFT. 
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Figure 95: Average Blood Oxygen Level During Pouring Water Test 
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CHAPTER 6: DISCUSSION 
 
6.1 Data Discussion 
 
During the Arthritis Hand Function Test, the use of the intervention groups (placebo, 
IMAK, and Veturo) caused an increase in the time subjects needed to complete the given task at 
hand. This can be seen in the results of every timed task within the AHFT. Within the two 
orthoses tested, there are more instances of the Veturo gloves scoring higher than the IMAK on 
tasks such as the cutting putty task where patients took an average of 52 seconds (± 29) when 
using the IMAK gloves but only took 48 seconds (± 13) when using the Veturo gloves. This 
pattern continued within the range of motion tasks where there were instances when the Veturo 
gloves increased the average maximum joint angle. For example, during the left hand thumb 
carpometacarpal abduction and adduction the Veturo gloves reached an average maximum angle 
of 56° (± 16) compared to the control of 55° (± 17) and IMAK of 55° (± 16). This pattern of the 
Veturo gloves performing better than the IMAK continues within the Rheumatoid Arthritis Pain 
Scale, where the pain experienced by patients was consistently lower than the IMAK gloves 
when subjects were wearing the Veturo. This can be seen during both the range of motion tasks 
and the AHFT. For example, during the pegboard dexterity task of the AHFT the average pain 
with the IMAK gloves in the right hand was 1.4 (± 1) and the left was 1.6 (± 1.6) while the 
average pain with the Veturo gloves in the right hand was 0.6 (± 1) and the left was 0.6 (± 1). 
There are less instances of the Veturo gloves having a higher average blood oxygen level when 
compared to the IMAK gloves during the AHFT however, these instances are not scarce and as 
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only four of the five data sets were able to be used for this data it should not dismiss previous 
information supporting the use of the Veturo gloves over the IMAK gloves. Similarly, the 
average temperatures when using the IMAK gloves were all higher than when using the Veturo 
gloves. However, data suggests that this is due to the higher insulation within the Veturo gloves 
as the temperature difference between the last test and after removing the gloves is higher for the 
Veturo gloves (5°) than the IMAK gloves (4°). 
Another pattern seen throughout most of this study was that the non-dominant (left) hand 
scored better than the dominant (right) hand while having an overall lower temperature reading. 
The left hand was shown to take less time performing the same tasks within the AHFT and reach 
higher maximum joint angles during the range of motion exercises. For example, during the 2-
point pinch strength task the maximum force achieved for the dominant hand was an average of 
5kg (± 2) while the maximum force achieved for the non-dominant hand was an average of 7kg 
(± 3). This was also seen within the RAPS for both the range of motion tasks and the AHFT. An 
example was during the finger metacarpophalangeal flexion and extension exercise when the 
maximum average pain experienced in the dominant hand was 2 (± 1) while the maximum 
average pain experience in the non-dominant hand was 1 (± 1). While the pattern of the non-
dominant hand scoring better is seen during these tests, it was also seen that the temperature of 
the non-dominant hand was consistently lower than that of the dominant. For example, during 
the grip strength task the maximum temperature of the non-dominant hand was 85.4°F (± 6.7) 
while the maximum temperature of the dominant hand was 87.2°F (± 6.8). The only instance 
where this pattern was not seen was during the collection of the blood oxygen level throughout 
the AHFT. Both hands were equal, maintaining the same highs and lows during the trials.  
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Throughout this pilot study it was seen that the Veturo gloves, although not always 
performing better than the control group, did perform better than the IMAK gloves. This 
performance was partnered with the pattern of the non-dominant hand resulting in better 
outcomes than the dominant hand, which was shown to cause more pain and function at a higher 
temperature. 
6.2 Study Design Modifications 
 
Possible study design modification outside of the limitations discussed later in this 
chapter are focused on increasing the complexity and difficulty of certain activities of daily 
living tested in the Arthritis Hand Function Test. During the picking up coins test, all four coins 
were placed individually on the table next to the coin box and participants were instructed to pick 
up one at a time. Feedback from subjects suggests that the test would be much more difficult, if 
not impossible, if the coins were stacked. In addition, feedback from participants suggests that 
milk cartons or bottles large in diameter and without a handle would be much more difficult 
when compared to the pitcher with a handle used in the pouring water test. Although these were 
the only design suggestions based off of feedback from patients, additional design modifications 
may be made with insight from more people with rheumatoid arthritis. 
This pilot study is fairly unique in that there are very few previously conducted studies 
focusing on the evaluation of thermal therapy orthoses. The only similar study was conducted in 
2016 by the Centre for Health Sciences Research at the University of Salford. This study 
examined the effects of orthoses worn at night by patients with rheumatoid arthritis and hand 
osteoarthritis. Although similar in that both this study and the one conducted at the University of 
Salford looked at outcomes such as pain and dexterity, the University of Salford study only had 
  126 
their subjects wearing the orthoses at night [36]. Implementing the orthoses being worn at night 
is another potential study design modification when conducting a long-term research study.  
6.3 Orthoses Design Suggestions 
 
The orthoses tested in this study are already a minimalistic design in that they are 
compression gloves without any assistive technology incorporated. This allows for users to 
experience as few limitations as possible with respect to overall hand function and range of 
motion. Since the IMAK gloves tended to score more poorly than the Veturos, it is suggested 
that these orthoses change the material that they are made of to one that is more conducive to the 
desired effect of the gloves. The inclusion of copper woven fabric was initially considered as 
there are studies showing their effectiveness [24, 25] however, more recent and extensive studies 
show that the treatment of RA with copper does not provide any advantage [54]. Therefore, it is 
suggested that orthoses made of more heat-generating material, such as thermal fabric as 
opposed to the cotton-spandex blend of the IMAK Arthritis Gloves. The Veturo orthoses are 
made of a polyethylene terephthalate material, trademarked as Celliant, which has been shown to 
have a positive effect on chronic pain when used in clothing such as socks [55]. This thermal 
material contains a polyester fiber infused with natural minerals such as aluminum oxide, quartz, 
and titanium dioxide [56]. Additional research is needed on these orthoses as they are equipped 
with material previously shown to have positive effects on patients suffering from symptoms 
similar to those of rheumatoid arthritis. Based on the results of this study, no other design 
modifications were deemed necessary.  
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6.4 Clinical Context 
 
Additional studies and information needs to be obtained prior to physicians prescribing 
these orthoses to their patients with rheumatoid arthritis. Specifically, the long-term effects of the 
gloves and their advantages or disadvantages on patients outside of stage 2. For example, studies 
focusing on the potential of orthoses to delay the progression of the disease should be taken into 
consideration. The work conducted in this study will contribute to the understanding of aids to 
symptoms of rheumatoid arthritis and the level of effectiveness of certain orthoses. Also, the 
limitations of these orthoses, such as the IMAK gloves not increasing the temperature enough to 
aid the user, can be taken into consideration for new orthoses designed to better assist the user.  
6.5 Power Analysis 
 
A power analysis was performed in order to determine the optimal number of participants 
for future studies [53]. The analysis was performed using the average palm temperature of the 
control and Veturo orthoses. Temperature was chosen as this is the leading cause of the 
decreased swelling and decreased pain experienced when using the orthoses as claimed by the 
manufacturers. Additionally, temperature is recorded during both the Arthritis Hand Function 
Test and during the range of motion exercises and is therefore, a constant outcome measure 
throughout this pilot study. Pain, although constantly recorded, was not chosen because it is a 
self-reported score. The following equation was used to perform the test: 
 
N ³ 2!"($%&'()$%&*)∆ -. 
 
The hypotheses to be tested are H0: µControl = µVeturo and HA: µControl ¹ µVeturo. The 
significance level of 0.05 will be used and a power of 0.8 to determine an absolute difference in 
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the average temperature of at least 2°F. The standard deviation of the palm temperature is 
believed to be no more than 3°F.  
 
N ³ 2!"($%&'()$%&*)∆ -.= 2/0($1.345)$1.6). 7. = 2/0(8.9:);.<=.). 7. = 17.7 
 
Therefore, at least 18 patients need to be enrolled in the study in order to be able to detect 
these desired results.  
This power analysis does not include all aspects of this pilot study and it is recommended 
that future studies perform analyses for every piece of information being collected in order to 
make the best decision on the sample size.  
6.6 Study Limitations  
 
This pilot study, although providing new insight into the use of wrist-hand orthoses by 
subjects with rheumatoid arthritis, has some limitations. First, this study consisted of all female 
patients who were right-hand dominant. Four of these patients were between the ages of 56 and 
69. This study did not include male patients, left-handed patients, or patients over the age of 69. 
Future studies will need to have an array of ages, an array of dominant hands, and patients who 
are both male and female. Also, this study only focused on patients categorized as having stage 2 
rheumatoid arthritis and did not analyze patients categorized as stage 1, 3, or 4. Lastly, all 
participants were only present for one day of trials. This did not allow for an adequate amount of 
information to be gathered regarding the long-term effects of the gloves. 
Additionally, during the palm temperature readings, the orthoses were not directly against 
the skin of the palm. Although the palm temperature after removing the orthoses was recorded 
and visible, the difference between the last test reading and the temperature after removing the 
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gloves was not found to be significant (see Chapter 5.5.1.3). This temperature variation may be 
determined to be significant for other studies and should continue to be monitored.  
During the range of motion exercises, the Vicon Motion Capture system was used to 
collect the movement data. After collection, it was determined that numerous markers were 
missing from many of the frames within each trial. Although the system is programmed to 
interpolate the positions of the missing markers, this does not ensure 100% accuracy especially 
when upwards of 10% of a trial is theorized.  
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CHAPTER 7: OBSERVATIONS 
 
Throughout the testing and data collection process, a number of qualitative observations 
were made that were important to the study. These observations, although not quantitatively 
applicable to the conclusion, are significant in that some could help in explaining certain results 
and others could aid future studies in this subject area.  
The first observation was made regarding the attire of all subjects who participated in this 
study; they wore shoes without laces and, all but one patient, shirts without buttons. After 
inquiring about their daily lives and performing parts of the Arthritis Hand Function Test, it was 
ascertained that the lack of shoe laces and buttons was not coincidental. On a daily basis, the 
subjects participating in this study did not wear clothing that had laces or buttons because it was 
too difficult and too discouraging for them to constantly struggle with these types of apparel. 
This could have had an influence on the results of the button board and shoe-lacing tasks within 
the AHFT; if the participants do not perform certain activities of daily living on a routine basis, 
they are no longer activities of daily living and would cause the time to completion to be longer 
than expected.  
Another observation was made during the completion of the AHFT with two of the five 
subjects. Both of their fingernails were longer than those of the other patients and seemed to 
make tasks such as the coin pick-up and pegboard dexterity tests easier. The longer nails were 
used to pick-up the coins and pegs without much use of the fingers and joints affected by 
rheumatoid arthritis. This being said, their long fingernails also seemed to be a hindrance during 
other tasks such as the button board test and shoe lacing test. Although not quantitatively 
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applicable, this observation could have an effect on the overall results of these individual tests. 
Based on this observation, it is suggested that future studies consider long fingernails as an 
excluding factor in order to secure veracity. 
Similar to the long finger nails, it was observed that there were instances where the 
orthoses, specifically the placebo gloves, got in the way of the subject completing a task. This 
was most clear during the safety pin fastening test when multiple patients fastened together tips 
of the gloves with the cloth. Since this would not classify as a correct performance of the AHFT, 
these instances were not recorded and were repeated to ensure accuracy.  
It was also observed that as the trials progressed, the ability of the subject to complete a 
task and the pain associated with the task improved. This could have been due to the fact that 
subjects all began testing during the morning and as the day progressed, their morning stiffness 
dissipated which allowed them better overall hand function. Additionally, as each trial 
progressed patients became more familiar with the motions and tasks they were asked to 
complete. This may have caused patients to become more confident in their abilities as they were 
familiarized with the tests.  
During the first trial of the lifting cans task in the AHFT, one 10.5oz soup can was 
initially placed on the tray and the subject was asked to lift the weighted tray. Once they had 
done this, the patient was asked if they would like another can added. If they said yes, another 
can was added and they were asked to perform the lifting exercise again. This was repeated until 
the patient felt they could not add anymore cans or the maximum of 12 was reached. Once their 
maximum number was reached during the first trial, the subsequent trials immediately began at 
this number and did not start at the beginning. For example, if patient X was able to lift all 12 
cans during the first trial, the following trials began with them lifting all 12 cans as opposed to 
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beginning with 1 and working their way back up to 12 cans. This was done to prevent fatigue 
and to decrease pain related to this unnecessary repetitive motion. However, during the first trial 
of adding a single can at a time, it was observed that patients became more fatigued and 
disconcerted during the repetitive motion. This could have affected their ability to reach their 
maximum number and more importantly, objectively report the pain associated with only the last 
(maximum number of cans) lift.  
Some patients reported that they had more severe pain elsewhere, whether from arthritis 
or another disease. This could have affected their ability to accurately gauge the pain in their 
hands when performing the range of motion tasks or AHFT. The ambient pain would not only 
make it difficult to isolate the pain associated with only their hands but may also make the pain 
from their RA in their hands and fingers seem less severe than it actually is. This could have 
caused the recorded pain data to be less accurate than preferred.  
In addition to performing tasks that they specifically avoided (button board and shoe-
lacing) by wearing alternate clothing, patients also admitted to completing other tasks within the 
AHFT that they do not attempt at home. Participants verbalized that they felt they could fulfill 
these tasks, such as the cutting putty and lifting the weighted tray, because of the orthoses, even 
with the placebo orthosis. This therefore presents a possible psychological influence of the 
orthoses that causes patients to become more confident in themselves and attempt tasks they 
otherwise would not. One such psychological explanation is the well-known placebo effect 
referring to the “positive cognitive modulation of behaviors and outcomes related to medical 
treatment” [57]. The combined outcome of the placebo effect and patient expectancy, the belief 
that the intervention will help, is common within the medical industry, especially with respect to 
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pain [58]. The placebo effect, along with patient expectancy, may explain why patients felt they 
could successfully perform tasks that they otherwise felt too daunting to take on.  
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CHAPTER 8: CONCLUSION 
 
8.1 Patient History Survey and Pain Catastrophizing Scale 
8.1.1 Patient History Survey 
 
The patient history survey, with the Health Assessment Questionnaire incorporated [2], 
was given to participants prior to the start of the first trial. This survey gathered information 
about the health and well-being of each subject in addition to their pain levels when completing 
specific activities of daily living. Patients varied slightly however; overall, participants indicated 
that in spite of the numerous activities of daily living affected by their RA (63 out of 120), four 
of the five patients self-reported that they were in “very good” health and that their RA affects 
them, on average, 53% of the time. Patients were also affected by other health factors, such as 
heartburn and mouth sores, 32% of the time. This self-reported data suggests that the participants 
of this study may be moderately affected by their RA but may still have been able to lead 
independent lives.  
8.1.2 Pain Catastrophizing Scale 
 
As part of the personal history survey, subjects were asked to complete the Pain 
Catastrophizing Scale (PCS) [3]. This scale was used to determine the psychological effect of 
pain on each of the subjects. Within this study, patients fell at or below the 50th percentile of the 
PCS. This information implies that the participants of this study may not focus on their pain or 
allow it to affect them in a severely catastrophic manner psychologically.  
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8.2 Arthritis Hand Function Test 
 
The Arthritis Hand Function Test was used to evaluate strength, dexterity, and overall 
function of the hands through a number of tasks [4]. Patients performed the entire test with the 
control, placebo, IMAK and Veturo orthoses and adhered to the test manual instructions for 
proper form and completion. After scoring and analyzing the results, it was determined that there 
were slight differences in the form of subjects requiring more time to complete certain tasks 
when using the orthoses or placebo when compared to the control. Within both of the orthoses 
tested, the Veturo glove scored consistently better than the IMAK. Therefore, this data suggests 
that while the use of orthoses may cause users to take more time to complete certain tasks, the 
use of the Veturo gloves may be more advantageous than the use of the IMAK gloves. 
8.3 Range of Motion Tasks 
 
Four range of motion tasks were used to evaluate the overall movement capabilities of the 
participants [9]. These motions were recorded using the Vicon Nexus motion capture system and 
analyzed using the C-Motion Visual 3D software. The average movements along with the 
maximum joint angles reached were all compared to determine if the differences were 
statistically significant. As there were some instances where the orthoses performed better than 
the control and placebo groups, it is implied that the use of the IMAK or Veturo orthoses may 
increase the range of motion potential of the user. 
8.4 Pain Scale 
 
During the course of this study, in conjunction with the Arthritis Hand Function Test and 
the range of motion tasks, subjects were asked to rate the pain experienced when performing 
each individual activity using the Rheumatoid Arthritis Pain Scale [10]. The scores were 
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compared and it was determined that the orthoses did provide relief by means of consistently 
having lower pain score results than the control or placebo groups. Within the two orthoses, the 
Veturo gloves were shown to have lower self-reported pain scores than the IMAK gloves. This 
data suggests that the use of orthoses may decrease the self-reported pain experienced by patients 
during the AHFT and range of motion tasks. It is also implied that between the two orthoses 
tested, the Veturo gloves may decrease the pain experienced more so than the IMAK gloves. 
8.5 Additional Outcome Measures 
8.5.1 Temperature 
 
Throughout the range of motion exercises and the Arthritis Hand Function Test, the 
temperature of the palm of the hand(s) was recorded to analyze the differences between using 
and not using the gloves. Temperature was recorded in order to assist in the measuring of blood 
flow and therefore, inflammation. During all of these exercises a pattern was identified where the 
non-dominant (left) hand functioned at a consistently lower temperature than the dominant 
(right) hand. Additionally, the temperature readings with the orthoses were much lower than the 
control group however, the temperature readings taken immediately after the gloves were 
removed were much higher than the temperature of the control. This information implies that the 
use of the thermal therapy gloves may increase the hand temperature as seen when comparing 
the readings taken after removing the gloves. Future studies should consider other forms of 
inflammation monitoring such as ultrasound in order to achieve the most accurate results 
possible. 
 
 
  137 
8.5.2 Blood Oxygen Level 
 
During each performance of the Arthritis Hand Function Test, the blood oxygen level 
was recorded after each individual task. This information was compared within each test, for 
example; within the right-hand pegboard dexterity the placebo, IMAK, and Veturo were all 
compared to the control. The blood oxygen levels were not found to have a discernable pattern 
and remained fairly equal, within each hand and when comparing both hands, throughout this 
pilot study. Therefore, the data suggests that the use of the thermal therapy orthoses may not 
increase or decrease the blood oxygen levels in the hands when performing the Arthritis Hand 
Function Test.  
8.6 Specific Aims 
 
Aim 1: Determine if each thermal therapy arthritic glove increases range of motion in patients 
by comparing the performance with and without the orthoses [8, 9]. 
The Veturo gloves were shown to increase the maximum joint angles more so than the 
IMAK gloves. Although this was not consistent throughout all four exercises, it is suggested that 
the use of thermal therapy arthritis gloves may increase range of motion in patients with stage 2 
RA. 
 
Aim 2: Determine if each thermal therapy arthritic glove decreases the amount of pain 
experienced by the patient when completing specific tasks using the Rheumatoid Arthritis Pain 
Scale [10]. 
Throughout both the AHFT and the range of motion exercises, it was shown that the self-
reported pain experienced by the participants was less when using a thermal therapy arthritis 
glove. Between the two orthoses tested, the Veturo gloves consistently scored lower on the 
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RAPS when compared to the IMAK gloves. This information implies that the use of the Veturo 
thermal therapy gloves may decrease the amount of pain experienced by patients when 
completing specific tasks using the Rheumatoid Arthritis Pain Scale. 
 
Aim 3: Determine if each thermal therapy arthritic glove increases hand strength, dexterity and 
overall function using the Arthritis Hand Function Test [4]. 
During the Arthritis Hand Function Test there were few instances where the orthoses 
scored better than the control. Most, if not all, of the time it was seen that the gloves caused a 
hindrance which led to the patient needing longer to complete the tasks. As 55% of the Arthritis 
Hand Function Test is scored based on the amount of time needed to successfully finish a test, it 
cannot be said that the orthoses scored better than the control. Consequently, this information 
implies that neither the IMAK nor the Veturo orthoses may increase hand strength, dexterity, or 
overall function during the Arthritis Hand Function Test. 
 
Aim 4: Determine the advantages and disadvantages of each thermal therapy arthritic glove by 
comparing the results of each test. 
Based on the results of the Arthritis Hand Function test, one of the disadvantages of the 
thermal therapy orthoses is that they increase the amount of time needed to complete a certain 
task, such as buttoning clothes or lacing a shoe. Alternatively, it was observed within the AHFT 
that subjects were attempting tasks they otherwise would not because of the expectation that the 
orthoses would make it possible for them to complete these activities. Although additional 
research needs to conducted, an advantage of the orthoses observed within the study was the 
added psychological confidence needed to complete tasks subjects deemed impossible. 
Additionally, throughout this pilot study it was shown that the use of the thermal therapy arthritis 
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gloves decreases the pain experienced by participants. This data suggests that while the use of 
orthoses may cause a need for an increased amount of time to complete activities of daily living, 
the gloves could provide a psychological advantage while possibly decreasing the overall pain 
experienced by the user. 
8.7 General Conclusion 
 
This study evaluated the overall hand function and ranges of motion in order to determine 
if the IMAK Arthritis Gloves and the Veturo Therapy Infrared Gloves aided the user by treating 
symptoms such as swelling and pain. Thermal therapy orthoses have been used by patients to 
treat these and similar symptoms in order to improve overall hand function and increase their 
independence [35]. The differences in the performances of each orthosis were visible throughout 
the study and showed that the use of the thermal therapy gloves may be advantageous to patients 
with stage 2 rheumatoid arthritis. While a visible difference in outcome measure from both the 
IMAK and Veturo gloves was seen throughout this pilot study, the IMAK Arthritis Gloves did 
not perform as well as the Veturo Therapy Infrared Gloves. The data suggests that although 
further research is needed into the long-term effects of these orthoses, the Veturo Therapy 
Infrared Gloves may be beneficial by reducing pain and increasing range of motion in users. In 
conclusion, this pilot study gave insight into the advantages and disadvantages of wrist-hand 
orthoses used to treat symptoms of rheumatoid arthritis and will provide a foundation for future 
studies.  
8.8 Future Studies 
 
This pilot study is meant to serve as a basis to design future experiments focusing on the 
use of thermal therapy orthoses by patients with rheumatoid arthritis in their hands. There are 
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multiple avenues for additional studies based off of this initial experiment, all of which will serve 
as influential research for this new field.  
It is recommended that longer durations of use be tested in order to determine any long-
term effects of thermal orthoses. By having participants use the orthoses for an extended period 
(i.e. 6 months) and coming in for multiple evaluations, the durability and lasting effect of thermal 
orthoses can be measured. Additionally, the combination of newly prescribed pharmaceutical 
interventions coupled with the use of orthoses can be tested in order to assist in determining the 
best course of treatment on an individual basis. This could also be done with the combination of 
different orthoses; static at night, as these have previously been shown to be helpful to patients 
with RA, and therapy gloves during the day. Lastly, further research should be pursued focusing 
on the psychological aspect of the use of these orthoses. It was seen in this study that patients 
were successfully completing tasks that they otherwise would not attempt because of their 
expectations of the orthoses. This, along with their perception of pain, are extensive influencers 
in the medical field. In conclusion, more information on the longstanding effects of thermal 
therapy orthoses would need to be gathered prior to clinicians prescribing these to their patients 
however, the personal account of users who have had success with these orthoses will continue 
to be influential to others.  
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APPENDIX A – PATIENT HISTORY SURVEY 
 
 
 
 
 
 
 
Personal History Survey 
 
IRB Study # Pro00029570 
 
The following survey is in regards to your personal, medical history. If at any time you have 
questions or concerns, please bring them up to a member of the study team. 
 
____________________________________ ____________________________________ 
Last Name      First Name 
 
_____________________  ____________________ ______________________ 
Birth Year    Gender   Year of RA Diagnosis 
 
_____________________________________________________________________________ 
Medication Taken for Symptoms of RA  
 
_____________________________________________________________________________ 
Orthoses (Braces) Used to Treat Symptoms of RA 
 
_____________________________________ ____________________________________ 
Phone Number     Email Address 
 
The following Health Assessment Questionnaire (HAQ) will be used in conjunction with the 
Arthritis Pain Scale. 
 
_______________  ________________  _______________ 
Average Daily Pain  Most Severe Pain  Least Severe Pain  
 
My rheumatoid arthritis began with: 
_____ a fever ____ an accident ____ other, describe _______________________ 
Patient # 
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My rheumatoid arthritis affects: 
___ my fingers ___ my hands/wrists  ___ my elbows ___ my shoulders 
___ my neck  ___ my back   ___ my toes  ___ my feet/ankles 
___ my knees  ___ my hips 
 
My blood tests reveal: 
Rf factor  ___ Negative ___ Positive Titer ___ Not tested 
Anti-CCP ___ Negative ___ Positive Titer ___ Not tested 
HLA-DR4 ___ Negative ___ Positive  ___ Not tested 
 
Who diagnosed your rheumatoid arthritis? 
___ Primary Physician ___ Rheumatologist  ___ Self 
 
How did your arthritis affect your ability to carry out your daily life this week? 
0 = can always complete with no difficulty, 2 = can usually do it, 4 = can sometimes do it but 
usually have much difficulty, 6 = unable to do it 
 
Dressing and Grooming: Are you able to: 
Dress yourself including shoelaces and buttons _____ 
Shampoo your hair _____ 
Arising: Are you able to: 
Stand up from a straight chair _____ 
Get in and out of bed _____ 
Eating: Are you able to: 
Cut your meat _____ 
Lift a full glass to your mouth _____ 
Open a new milk carton _____ 
Walking: Are you able to: 
Walk outdoors on flat ground _____ 
Climb 5 steps _____ 
Go down five steps _____ 
Walk on uneven ground _____ 
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Please check any aids or Devices that you usually use for any of the above activities: 
___ Aids used for dressing (button hook, zipper pull) ___ Special/built up chair 
___ Special/built up utensils ___ Cane ___ Walker ___ Crutches ___ Wheelchair 
 
Please check any categories that you usually need help from another person: 
___ Dressing and Grooming ___ Arising ___ Eating ___ Walking 
 
How did your arthritis affect your ability to carry out your daily life this week? 
0 = can always complete with no difficulty, 2 = can usually do it, 4 = can sometimes do it but 
usually have much difficulty, 6 = unable to do it 
 
Hygiene: Are you able to: 
Wash and dry your body _____ 
Take a tub bath _____ 
Get on and off the toilet _____ 
Reach: Are you able to: 
Reach above your head and get down a 5lb bag of sugar _____ 
Bend down to pick up clothing from the floor _____ 
Grip: Are you able to: 
Open car doors _____ 
Open previously opened jars _____ 
Turn faucets on and off _____ 
Activities: Are you able to: 
Run errands and shop _____ 
Get in and out of a car _____ 
Do chores such as vacuuming and yard work _____ 
Dance _____ 
Gold _____ 
Swim _____ 
 
Please check any aids or Devices that you usually use for any of the above activities: 
___ Raised toilet seat  ___ Bathtub set ___ Bathtub bar  
___ Long handled appliances in bathroom  ___ Long handled appliances for reach 
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___ Jar opener (for previously opened jars) 
 
Please check any categories that you usually need help from another person: 
___ Hygiene ___ Reach ___ Grip ___ Activities 
 
How’s your overall health? 
In general, would you say that your overall health is: 
___ excellent ___ very good  ___ good ___ fair ___ poor 
 
Morning Stiffness: Are you stiff in the morning? ___ Y ___ N 
If yes, how long does the stiffness last: ___ hours ___ minutes 
 
Pain: Please mark how much pain you have had in the last week: 
Place a single vertical line ( | ) through the link to indicate the severity of pain. 
None              Severe 
0                100 
 
When you wake up in the morning, do you ache? ___Y ___N 
If yes, how long does your pain last? ___ hours ___ minutes 
 
Do you take anything for the pain? ___ Y ___ N 
If yes, please list with dosage: _____________________________________________________ 
 
Have you ever had any of these symptoms today, this past week, this past month? 
General 
Fever   ___ today ___ this week  ___ this month 
Dizziness  ___ today ___ this week  ___ this month 
Tiredness (fatigue) ___ today ___ this week  ___ this month 
 
Head, eyes, nose, mouth, throat 
Blurred vision  ___ today ___ this week  ___ this month 
Ringing in your ears ___ today ___ this week  ___ this month 
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Hearing difficulties ___ today ___ this week  ___ this month 
Mouth sores  ___ today ___ this week  ___ this month 
Dry mouth  ___ today ___ this week  ___ this month 
Loss/change in taste ___ today ___ this week  ___ this month 
Headache  ___ today ___ this week  ___ this month 
 
Chest, lungs, heart 
Chest pain  ___ today ___ this week  ___ this month 
Shortness of breath ___ today ___ this week  ___ this month 
Wheezing  ___ today ___ this week  ___ this month 
 
Musculoskeletal 
Joint pain  ___ today ___ this week  ___ this month 
Joint swelling  ___ today ___ this week  ___ this month 
Leg/ankle swelling ___ today ___ this week  ___ this month 
Low back pain ___ today ___ this week  ___ this month 
Muscle pain  ___ today ___ this week  ___ this month 
Neck pain  ___ today ___ this week  ___ this month 
Weakness of muscles ___ today ___ this week  ___ this month 
 
Gastrointestinal tract 
Loss of appetite ___ today ___ this week  ___ this month 
Nausea  ___ today ___ this week  ___ this month 
Heartburn  ___ today ___ this week  ___ this month 
Indigestion  ___ today ___ this week  ___ this month 
Pain in stomach area ___ today ___ this week  ___ this month 
Liver problems ___ today ___ this week  ___ this month 
Lower abdomen pain ___ today ___ this week  ___ this month 
Diarrhea  ___ today ___ this week  ___ this month 
Constipation  ___ today ___ this week  ___ this month 
Black/tarry stools ___ today ___ this week  ___ this month 
Vomiting  ___ today ___ this week  ___ this month 
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Neurological and Psychological 
Sadness  ___ today ___ this week  ___ this month 
Depression  ___ today ___ this week  ___ this month 
Insomnia  ___ today ___ this week  ___ this month 
Nervousness  ___ today ___ this week  ___ this month 
Trouble thinking ___ today ___ this week  ___ this month 
 
Skin 
Easy bruising  ___ today ___ this week  ___ this month 
Hives/welts  ___ today ___ this week  ___ this month 
Itching   ___ today ___ this week  ___ this month 
Rash   ___ today ___ this week  ___ this month 
 
Pregnancy 
___ Y ___ N ___ NA 
 
Eating Habits 
Breakfast: 
I usually eat a ___ hearty ___ light breakfast 
I usually ___ do ___ do not snack before lunch 
Lunch: 
I usually eat a ___ hearty ___ light lunch 
I usually ___ do ___ do not snack before dinner 
Dinner: 
I usually eat a ___ hearty ___ light dinner 
I usually ___ do ___ do not snack before going to bed 
Each week I usually eat:  
___ servings of vegetables that are  ___ conventional ___ organic 
___ servings of fruits that are  ___ conventional ___ organic 
___ servings of proteins that are  ___ conventional ___ organic 
___ raw nuts 
___ raw almonds 
___ roasted nuts 
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___ fat    ___ olive oil   ___ organic butter  
___ conventional butter ___ sea salt   ___ table salt 
___ vegetable oils  ___ hydrogenated oils  ___ fish oil   
___ fried foods 
 
Changing: 
I am changing __________________________________________________ 
I have been ____________________________________________________ daily for ___ today, 
____ weeks, or ____ months 
 
Water 
I drank _____ glasses of water before. Now I drink ____ glasses of water daily. 
The water I drink is:  ___ tap  ___ bottled (brand ________ or ____ mixed brands) 
   ___ filtered ___ distilled 
 
Exercise 
I exercise ___ daily ___ weekly ___ monthly 
I      ___ walk ___ do yoga ___ water exercises ___ garden ___ dance 
     Other ______________________________________________________ 
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Age:_____ Sex: M(__) F(__) 
 
Everyone experiences painful situations at some point in their lives. These experiences may include 
headaches, tooth pain, joint or muscle pain. People are often exposed to situations that may cause 
pain such as illness, injury, dental procedures or surgery. 
 
We are interested in the types of thoughts and feelings that you have when you are in pain. Thirteen 
statements are listed below describing different thoughts and feelings that may be associated with 
pain. Using the following scale, please indicate the degree to which you have these thoughts and 
feelings when you are experiencing pain. 
 
0 ‒ not at all 1 ‒ to a slight degree 2 ‒ to a moderate degree 3 ‒ to a great degree 4 ‒ all the time 
 
When I’m in pain... 
1  I worry all the time about whether the pain will end. 
2  I feel I can’t go on. 
3  It’s terrible and I think it’s never going to get any better. 
4  It’s awful and I feel that it overwhelms me. 
5   I feel I can’t stand it anymore. 
6   I become afraid that the pain will get worse. 
7  I keep thinking of other painful events. 
8  I anxiously want the pain to go away. 
9  I can’t seem to keep it out of my mind. 
10  I keep thinking about how much it hurts. 
11  I keep thinking about how badly I want the pain to stop. 
12  There’s nothing I can do to reduce the intensity of the pain. 
13  I wonder whether something serious may happen. 
 
 
 ...Total 
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APPENDIX B – ARTHRITIS HAND FUNCTION TEST (AHFT) 
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APPENDIX C – RANGE OF MOTION TASKS 
 
 
 
 
Figure 96: Metacarpophalangeal Flexion and Extension 
 
 
 
Figure 97: Proximal Interphalangeal Flexion and Extension 
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Figure 98: Carpometacarpal Abduction and Adduction 
 
 
 
Figure 99: Thumb Metacarpophalangeal Flexion and Extension 
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Faculty of Medicine 
Department of Occupational Science & 
Occupational Therapy 
T325 - 2211 Wesbrook Mall 
Vancouver, BC Canada V6T 2B5 
 
P: 604 822 7392 | F: 604 822 7624 
os.ot@ubc.ca | www.osot.ubc.ca 
M E M O R A N D U M 
 
To: Brittany Mott, Graduate Student 
 University of South Florida 
From: Catherine Backman, PhD, FCAOT  
 Professor 
Date: March 7, 2018 
Re: Reproduction of items Arthritis Hand Function Test (AHFT) Manual 
 
This memorandum confirms permission for you to reproduce test items and/or assessment 
forms from the AHFT Manual in your graduate thesis submitted to the University of South 
Florida. Please acknowledge the source and permission, e.g., 
 
Reproduced from Backman, C., & Mackie, H. (1997). Arthritis Hand Function Test Manual. 
Vancouver, BC. Available from The University of British Columbia Department of 
Occupational Science & Occupational Therapy, www.osot.ubc.ca. With permission of the 
authors. 
 
You may reproduce the entire manual for sharing with a limited audience comprised of your 
thesis supervisory/examining committee. 
 
Please do not reproduce the manual in its entirety as part of a thesis that is made publicly 
available, for instance, in your university’s library or repository of theses and dissertations. 
 
Good luck with your project. 
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User agreement
Special Terms
Mapi Research Trust, a non-for-profit organisation subject to the terms of the French law of 1st July 1901, registered in 
Carpentras under number 453 979 346, whose business address is 27 rue de la Villette, 69003 Lyon, France, hereafter referred 
to as “MRT” and the User, as defined herein, (each referred to singularly as a “Party” and/or collectively as the “Parties”), do 
hereby agree to the following User Agreement Special and General Terms:
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
Recitals
The User acknowledges that it is subject to these Special Terms and to the General Terms of the Agreement, which are included 
in Appendix 1 to these Special Terms and fully incorporated herein by reference.  Under the Agreement, the Questionnaire 
referenced herein is licensed, not sold, to the User by MRT for use only in accordance with the terms and conditions defined 
herein.  MRT reserves all rights not expressly granted to the User. 
The Parties, in these Special Terms, intend to detail the special conditions of their partnership.
The Parties intend that all capitalized terms in the Special Terms have the same definitions as those given in article 1 of the 
General Terms included in Appendix 1.
In this respect, the Parties have agreed as follows:
 
Article 1. Conditions Specific to the User
        Section 1.01      Identification of the User
User Name Mott Brittany
Legal Form Student
Address 20041 Heritage Point Dr 
Florida 
33647 Tampa 
Country United States of America
Email address bmott@mail.usf.edu
        Section 1.02      Identification of the Questionnaire
Title Pain Catastrophizing Scale (PCS) 
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© Mapi Research Trust. The unauthorized modification and use of any portion of this document is prohibited.
Author(s) Sullivan Michael JL 
Owner
Michael Sullivan (Canada)
Copyright Copyright © 1995 Michael JL Sullivan. All right reserved
Original bibliographic references
Sullivan MJL, Bishop SR and Pivik J. The Pain Catastrophizing Scale: development and 
validation. Psychological assessment. 1995;7(4):524-532 (abstract)
 
Article 2. Rights to Use
        Section 2.01      Context of the Use of the Questionnaire
The User undertakes to only use the Questionnaire in the context of the Study as defined hereafter.
Context of Use Other project
Title Comparison of Thermal Glove Hand-Wrist Orthoses in Their Effectiveness on 
Rheumatoid Arthritis
Disease or condition Rheumatoid Arthritis
Start 11/2017
End 07/2018
Description of the project This project hopes to determine the effectiveness of three different orthoses used by 
patients with rheumatoid arthritis in their hands and is interested to see if the pain 
behavior (using the PCS) of the subjects influences the outcome of the study.
Presentation format of project Student Masters Thesis
        Section 2.02      Conditions for Use
The User undertakes to use the Questionnaire in accordance with the conditions for use defined hereafter.
(a)     Rights transferred
Acting in the Owner’s name, MRT transfers the following limited, non-exclusive rights, to the User (the “Limited Rights”)
              (i) to use the Questionnaire, only as part of the Study; this right is made up exclusively of the right to communicate 
it to the Beneficiaries only, free of charge, by any means of communication and by any means of remote distribution known or 
unknown to date, subject to respecting the conditions for use described hereafter; and
              (ii) to reproduce the Questionnaire, only as part of the Study; this right is made up exclusively of the right to 
physically establish the Questionnaire or to have it physically established, on any paper, electronic, analog or digital medium, and 
in particular documents, articles, studies, observations, publications, websites whether or not protected by restricted access, CD, 
DVD, CD-ROM, hard disk, USB flash drive, for the Beneficiaries only and subject to respecting the conditions for use described 
hereafter; and
              (iii) Should the Questionnaire not already have been translated into the language requested, the User is entitled to 
translate the Questionnaire or have it translated in this language, subject to informing MRT of the same beforehand by the 
signature of a Translation Agreement indicating the terms of it and to providing a copy of the translation thus obtained as soon 
as possible to MRT.
The User acknowledges and accepts that it is not entitled to amend, modify, condense, adapt, reorganise the Questionnaire on 
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any medium whatsoever, in any way whatsoever, even minor, without MRT’s prior specific written consent.
(b)     Specific conditions for the Questionnaire
Use in Individual clinical practice or Research study / project•
User shall:
           - Cite the reference publications
           - never duplicate, transfer or publish the Questionnaire without indicating the Copyright Notice
           - Insert the Owner’s copyright notice on all pages/screens on which the Questionnaire will be presented   
           - Mention the following information: “The Questionnaire contact information and permission to use: Mapi Research 
Trust, Lyon, France – Internet: https://eprovide.mapi-trust.org ”
           - In case of use of an IT Company (e-vendor), User shall check with Mapi Research Trust that the IT Company has 
signed the necessary License Agreement with Mapi Research Trust before developing the electronic version of the Questionnaire
 
In the case of use of an electronic version of the Questionnaire in academic studies, the User undertakes to respect the following 
special obligations:
           - Submit the screenshots of all the Pages where the Questionnaire appears to Mapi Research Trust before release for 
approval and to check that the above-mentioned requirements have been respected.
 
In the case of use of an electronic version of the Questionnaire in commercial studies / projects, the User undertakes to respect 
the following special obligations:
           - For the first migration of the Questionnaire (generally the original version) into a specific electronic device
                        - Review of screenshots:
After implementation of the Questionnaire into the device, the user and/or IT Company will generate screen captures 
(screenshots) of the original questionnaire as displayed in the device. These will be reviewed by Mapi to check that they are 
consistent with the original paper version in terms of presentation, content and completion except for specific instructions related 
to the electronic administration. Corrections that may be needed will be reported to the user and/or IT Company. In this case, 
screenshots after correction will be generated for another round of review by Mapi until all screenshots are approved.
                        - Usability testing:
Usability testing is a methodology which aims to examine whether respondents are able to use a device and associated software 
as intended. Major issues of concern in usability testing typically include device complexity, navigation and response selection for 
example.
The objective of this investigation is to ensure that the electronic version of the questionnaire as included in the device meets 
usability criteria, focusing on functional aspects and respondents’ understanding of instructions. Usability testing consists in 
interviews with patients where patients will complete the electronic version of the Questionnaire on the device and comment on 
their understanding of the instructions, ease of use and handiness of the device. A Usability testing report presenting results will 
be produced. If any changes are recommended, these will be implemented by the user and/or IT Company. If issues raised by 
respondents are rated as major, the user and/or IT Company may need to perform additional developments and another round of 
interviews may be needed.
The review of screenshots is mandatory. The usability testing is highly recommended by Mapi, however should the User and/or 
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IT Company decide not to perform this step, Mapi Research Trust shall not be held responsible for any consequence and 
expense associated with this decision which shall remain the User and/or IT Company’s sole liability.
The review of screenshots and usability testing, when and if performed, shall be performed exclusively by Mapi and shall be 
sponsored by the User.
The performance of the review of screenshots and usability testing will result in a certification of the electronic device original 
version of the Questionnaires by Mapi for future licenses.
           - For the migration of other language versions of the Questionnaire on an existing certified specific electronic device
                        - Update version
After the electronic device original version of the Questionnaire is fully ready, the Questionnaire’s language versions developed 
for paper administration will be updated to reflect the changes in wording of instructions implemented in the electronic device 
original version of the questionnaire.
Native speakers of the languages will reflect the changes made to the electronic device original version of the Questionnaire and 
will provide English equivalents of all changes made for Mapi’s quality control.
                        - Review of screenshots:
After implementation of the Questionnaire into the device, the user and/or IT Company will generate screen captures 
(screenshots) of the original questionnaire as displayed in the device. These will be reviewed by Mapi to check that they are 
consistent with the original paper version in terms of presentation, content and completion except for specific instructions related 
to the electronic administration. Corrections that may be needed will be reported to the user and/or IT Company. In this case, 
screenshots after correction will be generated for another round of review by Mapi until all screenshots are approved.
The update of version and review of screenshots are mandatory. These steps shall be performed exclusively by Mapi and shall 
be sponsored by the User.
The performance of the update of version and review of screenshots will result in a certification of the electronic device language 
version of the Questionnaires by Mapi for future licenses.
Use in a publication or on a website with unrestricted access:•
In the case of a publication, article, study or observation on paper or electronic format of the Questionnaire, the User undertakes 
to respect the following special obligations:
           -  not to include any full copy of the Questionnaire, but a protected version with the indication “sample copy, do not 
use without permission”
           -  to indicate the name and copyright notice of the owner
           -  to include the reference publications of the Questionnaire
           -  to indicate the details of MRT for any information on the Questionnaire as follows: contact information and 
permission to use: Mapi Research Trust, Lyon, France – Internet: https://eprovide.mapi-trust.org/
           -  to provide MRT, as soon as possible, with a copy of any publication regarding the Questionnaire, for information 
purposes
           -  to submit the screenshots of all the Pages where the Questionnaire appears to MRT before release to check that 
the above-mentioned requirements have been respected.
Use for dissemination:•
           - On a website with restricted access:
In the case of publication on a website with restricted access, the User may include a clean version of the Questionnaire, subject 
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to this version being protected by a sufficiently secure access to only allow the Beneficiaries to access it.
The User undertakes to also respect the following special obligations:
           -  to indicate the name and copyright notice of the owner
           -  to include the reference publications of the Questionnaire
           -  to indicate the details of MRT for any information on the Questionnaire as follows: contact information and 
permission to use: Mapi Research Trust, Lyon, France – Internet: https://eprovide.mapi-trust.org/
           -  to submit the screenshots of all the Pages where the Questionnaire appears to MRT before release to check that 
the above-mentioned requirements have been respected.
 
           - On promotional / marketing documents
In the case of publication on promotional/marketing documents, the User undertakes to respect the following special obligations:
           -  to indicate the name and copyright notice of the Owner
           -  to include the reference publications of the Questionnaire
           -  to indicate the details of MRT for any information on the Questionnaire as follows: contact information and 
permission to use: Mapi Research Trust, Lyon, France – Internet: https://eprovide.mapi-trust.org/
           -  to provide MRT, as soon as possible, with a copy of any publication regarding the Questionnaire, for information 
purposes
           -  to submit the screenshots of all the Pages where the Questionnaire appears to MRT before release to check that 
the above-mentioned requirements have been respected.
 
For any other use not defined herein, please contact MRT for the specific conditions of use and access fees (if applicable).
 
Article 3. Term
MRT transfers the Limited Rights to use the Questionnaire as from the date of delivery of the Questionnaire to the User and for 
the whole period of the Study.
Article 4. Beneficiaries
The Parties agree that the User may communicate the Questionnaire in accordance with the conditions defined above to the 
Beneficiaries involved in the Study only, in relation to the Study defined in section 2.01.
 
Article 5. Territories and Languages
MRT transfers the Limited Rights to use the Questionnaire on the following territories and in the languages indicated in the table 
below:
Questionnaire Language
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PCS English for the USA
 
Article 6. Price and Payment Terms
The User undertakes in relation to MRT to pay the price owed in return for the availability of the Questionnaire, according to the 
prices set out below, depending on the languages requested and the costs of using the Questionnaire, in accordance with the 
terms and conditions described in section 6.02 of the General Terms included in Appendix 1.
ROYALTY FEES*
Commercial users 
Cost per study 1 100€
Cost per language 550 €
Funded academic research
Cost per study Free
Cost per language Free
Not funded academic users
Cost per study Free
Cost per language Free
DISTRIBUTION 
FEES*
Commercial users
Cost per study 1 000 €
Cost per language 500 €
Funded academic research
Cost per study 300 €
Cost per language 50 €
Not funded academic users
Cost per study Free
Cost per language Free
 
Agreed and acknowledged by
Mott Brittany
30-Oct-2017
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